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Abstract
HIV infection is a known co-factor in the increased incidence of sepsis which is a
state of endotoxin tolerance (ET). During ET, with repeated exposure to non
pyrogenic amounts of endotoxin, there is an imbalance in pro- and anti
inflammatory cytokines when re-challenged with the endotoxin. We hypothesized
that the ET state would be exacerbated in the HIV-1 transgenic (HIV-1Tg) rat,
which has 7 of the HIV-1 viral proteins expressed without viral replication. Upon
measuring the gene-expression we found that IL-1a, !L-1J3, IFN-y, Cc12, 7 and 9
were upregulated to a greater extent in the spleen and cytokine receptors were
modulated differently in the brain of the HIV-1Tg rat versus control in the ET state,
indicating that the continuous presence of HIV-1 viral proteins alters the cytokine
and chemokine-profiles in the ET state. The expression of the j..I-opioid receptor
(MOR), which is known to mediate the rewarding and anti- nociceptive properties
of its ligands like morphine, is modulated by inflammatory cytokines. As MOR is
unregulated in the HIV-1Tg rat we hypothesized that rewarding properties of
morphine may be enhanced in HIV-1Tg rat and tested this hypothesis using the
conditioned preference placement (CPP) test. After developing a CPP, the rats
with morphine paired with the white compartment of the CPP apparatus failed to
show extinction after greater than 2 weeks of testing. Following extinction in rats
with morphine paired with the black chamber, both drug and stress failed to induce
a reinstatement of CPP. The morphine CPP procedure may sometimes result in

7

other forms of behavioural plasticity that does not conform to the
Pavlovian/memory model.
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Introduction
HIV-l infection and the HIV transgenic rat model
Following infection with the Human Immunodeficiency Virus-1 (HIV-1), a
burst of virus replication disseminates the virus to lymphoid organs. A
robust cellular and humoral immune response ensues within a few weeks
but the virus invariably escapes immune containment and results in chronic
persistent infection leading to advancing clinical disease(Fauci 1996). The
pathogenesis of HIV-1 infection results from the actions of HIV-1 viral
proteins, including the envelope glycoprotein 120 (gp120), on targeted cells,
such as macrophages and T-Iymphocytes (Clapham and McKnight 2001;
Cicala, Arthos et al. 2002; Jiang and Aiken 2006). Since 1996, highly active
antiretroviral therapy, or HAART-has produced dramatic improvements in
health and longevity for HIV-infected individuals (Palella, Delaney et al.
1998). HARRT regimens typically include two nucleoside (or nucleotide)
analogue reverse transcriptase inhibitors (NRTls) and either a protease
inhibitor or a non-nucleoside reverse-transcriptase inhibitor (NNRTI) (Ellis,
Calero et al. 2009). By inhibiting HIV replication at several stages in the
viral life cycle, HAART markedly reduces the likelihood that drug resistance
will develop (Ellis, Calero et al. 2009). Judicious use of antiretroviral
therapy, by suppressing viral replication and partially restoring immune
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function, can prevent opportunistic infections and markedly prolong survival
with HIV (Ellis, Calero et aL 2009). However, HAART drugs are limited in
their capacity to enter the CNS and other organs that are protected by tight
endothelial barriers. Thus, in this post-HAART era, the clinical challenge is
to identify the biological and physiological changes that occur due to the
persistent presence of HIV-1 viral proteins in the host even when active
viral replication is arrested (Jones and Perelson 2005; Vigano, Trabattoni et
ai. 2006).
Some HIV-1 viral proteins have been shown to affect the inflammatory
response by altering the production of cytokines. For example, the HIV-1
Tat protein can alter the LPS-induced production of IFN-(3 and IL-6 in blood
monocytes/macrophages(Yim HC 2009), and HIV-1 Vpr suppresses IL-12
production in human monocytes (Mirani M 2002). However, the effects of
HIV-1 viral proteins on immune function during a state of ET has not been
examined.
The HIV-1 transgenic (HIV-1Tg) rat model was developed with a functional
deletion of the gag and pol genes in the HIV-1 genome. It is, however,
under the control of the viral promoter and expresses seven of the nine HIV
genes (Reid, Sadowska et al. 2001). Thus. there is no active viral
replication but viral proteins are expressed in various organs' immune cells
and in the circulation (Reid. Sadowska et al. 2001). Clinical signs include
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wasting, mild to severe skin lesions, opaque cataracts, neurological signs,
and respiratory difficulty (Reid, Sadowska et at. 2001). While it is wellknown that HIV-1 affects the host target cells and causes the many
pathological manifestations of AIDS, it has also been shown gp 120 and
Tat, the HIV-1 viral proteins, can cause organ dysfunction independently
(Klotman and Notkins 1996; Bruggeman, Dikman et at. 1997; van Maanen
and Sutton 2003). It has been shown that, like HIV-1 infected patients, the
HIV-1Tg rat is immunodeficient. LPS-induced leukocyte-endotheiiai .
adhesion (LEA) is greatly attenuated in the HIV-1Tg rat(Chang 2007). In
addition, the HIV-1Tg rat shows signs of wasting and dies at a younger age
even though there is no growth retardation and no sign of anorexia
throughout its life span(Peng, Vigorito et al. 2010). It has been shown that
prior to manifesting signs of wasting the expression of HIV viral proteins in
various tissues changes(Peng, Vigorito et al. 2010). Reid and colleagues
showed that spliced and unspliced viral transcripts were expressed in the
spleen of HIV-1Tg rats(Reid, Sadowska et at 2001). Peng and colleagues
showed that in the HIV-1Tg rats at 10-11 months of age the expression of
Tat, gp120, nef, and vif viral protiens decreased significantly in the spleen
compared to 2-3 months of age, but increased Significantly in the spinal cord and
cerebellum(Peng, Vigorito et al. 2010). These rats also have decreased
alveolar macrophage expression of granulocyte-macrophage colony
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stimulating factor and impaired bacterial phagocytosis. which may increase
their susceptibility to pneumonia(Joshi, Raynor et al. 2008}. The HIV-1Tg
rat has also been shown to develop neurological deficits including motor
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(Reid, Sadowska et al. 2001) and cognitive deficits(Lashomb, Vigorito et al.
2009). Brain M incorporation and other markers of M metabolism are
upregulated in HIV-1 Tg rats (Basselin, Ramadan et al. 2011; Lund, Lucero
et al. 2011). The HIV-1Tg rat model, thus, exhibits some of the
characteristics of HIV-1 infected patients given HMRT (Chang, Beltran et
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al. 2007; Peng, Vigorito et al. 2010; Basselin, Ramadan et al. 2011; Lund,
Lucero et al. 2011).

Role ofInflammatory cytokines in HIV-l infection and
progression to AIDS
In HIV-1 infected individuals and persons with AIDS the immune system is

I
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loss of CD4-positive T helper cells (Lane, Masur et al. 1983) and
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hyperactivity as a result of B-cell activation (Holguin, O'Connor et al. 2004).
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dysfunctional at many levels. There is immunodeficiency induced due to

Additionally, inflammatory cytokines are modulated in HIV-1 infected
individuals by the actions of viral proteins, mainly gp120 (Holguin, O'Connor
et al. 2004). Cytokine changes in HIV-1 infection have been assessed by a
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variety of techniques, ranging from determination of cytokine gene
expression at the mRNA level to secretion of cytokine proteins in vivo and
in vitro. It has been shown that as soon as 5 days after detection of
viremia, (at least 100 HIV RNA copies/mI). cytokines IFNa and IL-15 were
elevated, followed by TNFa, CXCL 10, and IFNV. and then by IL-12 (Stacey, Norris
et al. 2009). Increased mRNA and protein levels of anti-inflammatory cytokine, IL
10. are detected rather late in HIV infection. after the increased expression of
proinflammatory cytokines(Stacey, Norris et a!. 2009). Location of cytokine
production in the very early phase of HIV infection is most likely local. However,
after the virus disseminates, cytokines are produced by distant sites such as distal
lymph nodes, gut-associated lymphoid tissue and genital draining(Haase 2010).
Changes in cytokine levels in HIV-1 infected persons can affect the function
of the immune system, and have the potential to directly impact the course
of HIV disease by enhancing or suppressing H IV replication (Breen 2002).
In particular, the balance between the pro-inflammatory cytokines IL 1~, IL
6, and TNF-a, which up-regulate HIV expression, and IL-10, which can act
both as an anti-inflammatory cytokine and a B-cell stimulatory factor, may
play an important role in the progression to AIDS (Chen, Zhou et al. 2005).
PrO-inflammatory cytokines, IL 1-~, TNF-a, and IL-6, were shown to be up
regulated in spinal cord glia activated by gp-120 (Breen 2002). It has been
shown that a non-pyrogenic dose of LPS induces a 7 to 38 fold increase in
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IL-1~

and TNF-a in HIV-1Tgrats and only 1 to 2 fold increase in these

cytokines in the F344 rats, whereas there was no significant difference
observed in IL-10 levels in HIV-1Tg rats vs. F344 rats, suggesting that there
is an imbalance of pro- vs. anti-inflammatory cytokine regulation with LPS
administration in HIV infection (Chen, Zhou et al. 2005).

Endotoxin Tolerance
The bacterial endotoxin, lippopolysccharide (LPS), is a well-characterized
glycolipid component of the gram-negative bacterial cell wall and is a potent
inducer of the inflammatory response in animals (Schletter, Heine et al.
1995). LPS is model molecule commonly used to study the inHarnmatory
responses caused by infection with bacteria, especially the induction and
actions of pro-inflammatory cytokines, including tumor necrosis factor-alpha
(TNF-a), interleukin (IL)-1~, IL-6, and anti-inflammatory cytokines like IL-10
(Turnbull and Rivier 1999). LPS and other Gram-negative bacterial
pathogens primarily engage the Toll like receptor-4 (TLR-4), which employs
signaling through two distinct adaptors - Myeloid differentation 88 (MyD88)
and TIR domain-containing adapter protein inducing IFN-~(TRIF) (Biswas

1

and Lopez-Collazo 2009). The MyD88 pathway leads to the activation of
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transcription factor NFKB which in the initial phase activates pro-
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inflammatory genes like TNFa, IL 1~, IL6 and IL 12~. The TRIF pathway
14
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leads to the activation of transcription factors IRF3 and STAT1 which

I

subsequently activate IFNJ3 and interferon-inducible genes like CCl5 and
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CXCl10, which ultimately leads to the induction of anti-inflammatory genes

I

like Il-10 (Biswas and lopez-Collazo 2009). These pathways are
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temporally segregated, MyD88 leads to the early activation of NFKB and the
TRIF pathway is implicated in mediating the late-phase activation of NFKB

1
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(Biswas and lopez-Collazo 2009). Crosstalk between the MyD88 and TRIF
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pathways exists and there are various negative regulators for each pathway

I

that are modulated by one of both of these pathways forming a complex
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signaling network (Biswas and lopez-Collazo 2009). It is the balance
between the production of pro-inflammatory cytokines and chemokines and
the subsequent production of anti-inflammatory cytokines that initiates a
robust inflammatory response in the innate immune system cells like
macro pages and monocytes (Biswas and lopez-Collazo 2009). A tight
regulation of the initial production of the pro-inflammatory cytokines is
required to protect against going into septic shock, an example of this
regulatory mechanism is Endotoxin Tolerance (Biswas and lopez-Collazo
2009). Exposure of the innate immune cells to minute amounts of
endotoxin, like lPS, makes them refractory to subsequent endotoxin
challenge establishing endotoxin tolerance. At a molecular level, during
endotoxin tolerance, there is a decrease in the production of pro
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inflammatory cytokines with an endotoxin re-challenge when compared to
the initial increase in pro-inflammatory cytokines with first exposure to the
endotoxin. And an increase in anti-inflammatory cytokines is observed with
an endotoxin re-challenge when compared to the initial anti-inflammatory
cytokines levels observed with first exposure to the endotoxin (Biswas and
Lopez-Collazo 2009). A clinical example of endotoxin tolerance is sepsis.
Following a systemic bacterial infection a dysregulated innate immune
response leads to sepsis. Sepsis is biphasic with the first phase being of
overt inflammation and a subsequent phase of "immunoconpromise", in
which the innate immune cells show a endotoxin tolerant phenotype
(Biswas 2009). The overt inflammation phase is called the systemic
inflammatory response syndrome (SIRS) in which there is an
overproduction of pro-inflammatory cytokines and organ failure{Adib
Conquy and Cava ilion 2009). The immunocomprornised or 'endotoxin
tolerant' state of spesi~ is termed compensatory anti-inflammatory response
syndrome or CARS. This is the state and is clinically correlated most with
secondary infections and mortality (Adib-Conquy and Cavaillon 2009).
Although, these two states of sepsis have been reported to be concomitant
by some researchers, the failure of anti-inflammatory therapies in sepsis
and the fact that most mortality is associated with patients in the
immunocompromised state, supports the biphasic nature of spesis(Biswas
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and Lopez-Collazo 2009). In sepsis patients blood monocytes have the
expression of proinflammatory cytokines like TNFa, IL-6, IL-1a, IL-1 band
IL-12, significantly diminished upon ex vivo LPS challenge as compared to
that of monocytes from healthy individuals (Munoz, Carlet et al. 1991;
Monneret, Venet et al. 2008; Draisma, Pickkers et al. 2009). At the same
time, upregulated expression of anti-inflammatory cytokines like IL-10,
TGFb and IL-1 RA were reported in these cells (Cavaillon, Adrie et al. 2005;
Monneret, Venet et al. 2008; Draisma, Pickkers et ai. 2009).

Clinical Relevance ofEndotoxin Tolerance with Respect to HIV-l
Infection
There is an association between chronic HIV infection and elevated plasma
endotoxin levels. Innate immune responses, which are dysregulated in ET,
are also altered in HIV infection (Lester, Yao et al. 2008). There is
increased expression and responsiveness of TLR in chronic HIV-1 infection.
The mRNA expression of TLR 6 , 7 and 8 was elevated in chronic
untreated HIV-1 infection and TLR 2,3 and 4 were additionally elevated in
advanced disease (CD4 cell count < 200 cells/ml) in peripheral blood
mononuclear cells(Lester, Yao et al. 2008). This TLR expression alteration
may perpetuate innate immune dysfunction and activation that underlies
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HIV pathogenesis (Lester, Vao et al. 2008). The cytokines/chemokines
modulated during ET playa role in HIV infection, replication (not applicable
for our model) and pathogenesis. Toll-like receptor 4 (TLR4) mediates
gram-negative bacteria activated signaling and significant changes in this
receptor's level is directly correlated with HIV infection (Lester, Vao et al.
2008). TNF-a upregulation leads to HIV-induced cytotoxicity (Westendorp,
Shatrov et al. 1995). Enhanced levels of Ccl2 in HIV-1 patients have been
associated with HIV-1-associated dementia (Ansari, Heiken et ai. 2007).
The Center for Disease Control (CDC) has identified HIV-1 infection as a
major reason for the increase in incidence of sepsis (Angus, Linde-Zwirble
et al. 2001). Opportunistic infections are a common feature in HIV-1
positive patients, who have a compromised immune status (Levy 1998). ET
leads to a similar immunosuppressed state. Identifying the mechanism by
which ET affects an already immune-compromised system, observed with
HIV-1 infection, could provide valuable information of clinical relevance.
We hypothesized that the continuous presence of HIV-1 viral proteins alters
the systemic immune response to bacterial endotoxins in terms of pro- and
anti-inflammatory cytokine and chemokine expression, and that this altered
immune response is exacerbated when the animal is in an ET state.
Specifically, we hypothesized that the production of pro-inflammatory
cytokines is diminished and anti-inflammatory cytokine production is
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enhanced in the HIV-1Tg rat rendered endotoxin tolerant. To test this

!

hypothesis, we examined the expression of an array of cytokines,

I!

chemokines, and their receptors in the serum, spleen, and brain of an
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endotoxin tolerant HIV-1Tg rat model in response to an LPS challenge.
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Morphine, and HIV infection
Morphine is a derivative of opium, which is the juice of the opium poppy,
Papver somniferum. Morphine was first used and still is used as a painkiller in the management of diseases like cancer and acquired
immunodeficiency syndrome (AIDS). When ingested, morphine can
produce a feeling of euphoria and a state of well-being; this makes it a

1
i

1
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i

popular choice to be used as a recreation drug which is often abused.
Approximately one third of the AIDS cases in the USA have been

1I

suggested to be related to the use of injected addictive drugs, such as

1

morphine, making it a very significant co-factor in contracting human

I

immunodeficiency virus type 1 (HIV-1) (Steffen, Blattler et al. 2001;
Banerjee, Strazza et al. 2011). The reason for higher addiction rates to
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morphine among HIV-1 infected individuals may be to over-come the
depression and stress due to the disease or that morphine addicted
persons may be more prone to risky sexual behaviour and in tum be more
prone to contracting HIV-1 infection (Beyrer 2007; Shetty 2011).

1
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Conversely, HIV-1 infected persons are more prone to be addicted to
morphine than the general population(Koulierakis, Gnardellis et al. 2000).
Thus, there may exist a bidirectional and synergistic relationship between
morphine abuse and the contraction of HIV-1 infection.
Most research in this field has been directed towards studying the effects of
drugs of abuse on HIV-1 viral infection and there is a paucity of studies
exploring the possible bidirectional feedback that may exist between drugs
of abuse and the persistence of viral proteins in HIV infection.

Immunosuppression associated with Morphine Abuse and HIV
infection
Chronic morphine abuse has been well-documented to result in severe
immune consequences. Pulmonary infections, caused by Mycobacterium,
Staphylococcus, Streptococcus, Haemophilus, and other bacteria, are
among the most common diagnoses of opiate abusers (Risdahl. Khanna et
al. 1998). Other serious diseases caused by microbial pathogens in opiate
users are AIDS (HIV), endocarditis (Staphylococcus, Enterococcus,
Pseudomonas, Klebsiella, Serratia, and Candida), abscesses and cellulitis
(StaphylococclJs, Streptococcus, Haemophilus, Enterobacter,
Pseudomonas, Klebsiella, Clostridium, Candida, and others), hepatitis A, S,
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and C (hepatitis A, S, and C viruses), sexually transmitted diseases, and
skeletal infections (Staphylococcus and Pseudomonas) (Risdahl, Khanna et
al. 1998). Studies concerning the effects of addictive drugs on
immunocompetence have taken on a greater urgency with the onset and
explosive expansion of the worldwide pandemic of AIDS caused by HIV,
which results in the collapse of the immune system, rendering individuals
highly susceptible to opportunistic microorganisms that normally would not
cause life-threatening infections. Intravenous (Lv.) drug abusers become
highly susceptible to HIV not only because of contaminated shared needles
but also because of associated immunosuppression caused by opioids
(Friedman, Om pad et al. 2003). Studies over the past few decades have
shown that opiates markedly affect many immune responses, both in vivo
and in vitro, in animal models such as rodents and mice, and even in
monkeys and swine, including altered resistance following challenge
infection with a microorganism. Morphine is known to supress the
functionality of both innate and adaptive immune cells (Friedman and
Eisenstein 2004; Dinda, Gitman et al. 2005; Roy, Wang et al. 2006).
Morphine suppresses pro-inflammatory signal in dendritic cells,
macrophage activation and phagocitosis(Wang, Ma et al. 2011; Wang, Ye
et al. 2011). TLR signalling and production of pro-inflammatory cytokines is
significantly modulated by morphine(Roy, Ninkovic et al. 2011) .

21

Several opiate receptors have been identified on cells of the nervous
system and immune system of animals and humans, with lJ, K, and V
subtypes predominating (Cabral 2006). These classical opiate receptors,
similar to cannabinoid receptors, are G-protein-coupled seven
transmembrane molecules. Opiates directly ligate lJand V opiate receptors
as well as non-classical opiate-like receptors on immune cells, and also
bind to similar receptors on CNS cells. Opioids have been reported to have
direct (House, Thomas et ai. 1996; McCarthy, Wetzel et ai. 2001) as well as
indirect effects (Chang, Wu et al. 1998; Roy, Charboneau et al. 2001) on
the immune system through the mediation of lJ, K, and 60pioid receptors as
well as non-classical opioid-Iike receptors. MOR ligands can mimick
chemoattractants (direct effect) (Simpkins, Taylor et al. 1984; Grimm, Ben
Baruch et al. 1998; Grimm, Ben-Baruch et al. 1998) and can inhibit
chemotaxis of cytokines and chemokines by (indirect effect) (Grimm, Ben
Baruch et al. 1998). Peterson and colleagues proposed that MOR ligands
"can be viewed as cytokines operating both within somatic immune tissues
and the CNS" (Peterson, Molitor et al. 1998). Treating astroglial cells with
IL-1~

increased MOR mRNA expression by 70-80% (Ruzicka, Thompson et

al. 1996); simultaneous treatment with IL-1 a and IL-1 ~ increased MOR
expression in primary cell cultures of human brain microvesicular
endothelial cells (Vidal, Patel et al. 1998). These studies were among the

22

first to report the link between cytokines and MOR and opened up the field
of neuroimmunology, showing that the immune system interacts with the
CNS by modulating the expression of neurotransmitter receptors which
mediate the effects of addictive substances. CCR5 and CXCR4 are the
main HIV-1 co-receptors, which cooperate sequentially with CD4 to
facilitate virus entry into target cells. A possible mechanism for increased
susceptibility to HIV-1 with morphine abuse is provided by studies that show
that the expression of CCR5 and CXCR4 in CD3{+) iymphoblasts and
CD14{+) monocytes is increased 3-5 folds by DAMGO, a selective MOR
agonist{Guo, Li et al. 2002; Wang, Barke et al. 2005). By enhancing
CXCR4 and CCR5 expression, opioids increase HIV-1 infection(Steele,
Henderson et al. 2003). Additionally, it has been shown by several studies
that morphine and other MOR agonists increase the expression of CCR5
and CXCR4 on glial cells{Miyagi, Chuang et al. 2000; Steele, Henderson et
al. 2003; Mahajan. Aalinkeel et al. 2005; Mahajan, Schwartz et al. 2005;
Burbassi, Aloyo et al. 2008; Happel, Steele et al. 2008; Bokhari, Yao et al.
2009). It has been postulated that morphine induces the expression of
these chemokine receptors by the modulation of cytokines , like IL-12 and
TNF-a, which are known to stimulate chemokine receptor expression(Hu,
Chao et al. 2000).
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Mechanisms ofmorphine immunomodulation
Although the specific mechanisms of the changes induced in the immune
system by morphine are not fully understood, the initial step is mediated
through the MOR, which is expressed on immune cells including
macrophages and lymphocytes as well as in the central nervous system
(CNS) (House, Thomas et al. 1996; Chang, Wu et al. 1998; McCarthy,
Wetzel et al. 2001; Roy, Charboneau et al. 2001). Expression of the MOR
can be modulated in both the immune system and neuronal cells by various
cytokines. IL-1 was the first cytokine that was demonstrated to increase the
mRNA level of MOR in endothelial cells (Vidal, Patel et al. 1998). IL4 was
shown to induce MOR transcripts in human primary blood cells, immune
cell lines, and dendritic cells (Kraus, Borner et al. 2001). IL6 induced only
induced MOR mRNA and not the ~ opioid receptor in a human
neuroblastoma cell line (Borner, Kraus et al. 2004). TNF-a was shown to
induce MOR gene transcription in primary human T lymphocytes, Raji B
cells, U937 monocytes, primary human polymorphonuclear leukocytes, and
mature dendritic cells (Kraus, Borner et al. 2003). Morphine also exerts an
indirect effect on immune cells through MORs located in the CNS. Several
stUdies indicate that morphine acts on central MORs and activates the
hypothalamic-pituitary-adrenal (HPA) axis resulting in the release of
glucocorticoids from the adrenal cortex (Gottlieb, Schroff et al. 1981).
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These studies indicate that cytokines and chemokines modulate the effects
of MOR ligands like morphine but these MOR ligands also have an effect
on the function of these immune molecules. Studies indicate that that
morphine use increases the progression of HIV-1 infection to AIDS through
its interaction with cytokines, chemokines, and their receptors (McCarthy,
Wetzel et al. 2001; Hahn, Jagwani et al. 2010; EI-Hage, Dever et al. 2011).
Morphine phosphorylates CXCR1 and CXCR2 receptors and induces
heterogeneous desensitization of these receptors thus inhibiting the
migration of CXC1 and CXC2 to their receptors (Grimm, Ben-Baruch et al.
1998). On the other hand, chemokines and their receptors, which are also
HIV-1 co-receptors, have been implicated in the neuropathogenesis of HIV
1 infections. Astrocytoma cell line U8? treated with morphine showed
significant down-regulation of IL-8 gene expression, whereas expression of
the IL-8 receptor CXCR2 was reciprocally up-regulated (Mahajan, Schwartz
et al. 2002). Furthermore, treatment of normal human astrocyte (NHAs)
with morphine suppressed IL-8 and macrophage-inflammatory protein-113
gene expression, whereas expression of their receptor genes, CCR3 and
CCR5, was simultaneously enhanced (Mahajan, Schwartz et at 2002).
These morphine-induced effects on U8? and NHA cells were reversed by
the MOR antagonist 13 -funaltrexamine. Morphine also enhanced the
constitutive expression of the MOR on astroglial cells (Mahajan, Schwartz
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et al. 2002). These results suggest that morphine has the potential to
increase HIV-1 co-receptor expression, promoting viral trafficking and
binding on infected cells as well as increasing CNS disease progression,
and increasing susceptibility to HIV infection. Opioid receptor selective
agonists have been shown to modulateinfection by HIV-1 and HTLV-1 by in

vitro syncytia formation (Nyland, Specter et al. 1998). Morphine promoted
the survival of CEMx174 cells in early stages of simian immunodeficiency
virus (SIV) infection in vitro, a modei system that has been used to study
HIV infection. Cell cycle analysis indicated that, in response to the
treatment with morphine, SIV-infected cells were accumulated in the C1
phase. The investigators suggested that the calcium-PKC-MAPK cascade
was involved in morphine prolonged survival of cells in the early stages of
virus infection(U, Hao et al. 2004). In an HIV-1 transactivator of
transcription (TAT)-transgenice mouse model morphine was shown to have
a major inhibitory effect on mitogen-induced IL-2 production. This decrease
of IL-2 production correlated with reduced percentages of CD4+ and CD8+
splenic lymphocytes (Garza, Prakash et al. 1996), These studies indicate
that morphine affects the responsiveness of immune cells to infectious
agents and their interaction with the HIV in vitro.
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Upregulation ofthe Mu-opioid receptor in HIV-l Tg rat brain
may enhance propensity for addiction
The persistent presence of HIV viral proteins may contribute to the
dysregulation of both the dopaminergic and opioidergic pathways, and may
lead to reward and addictive behaviors. Expression of the dopamine
receptor (01R) is increased in HIV-1Tg rats and methamphetamine-induced
behavior sensitization is more profound in the H IV-1 T 9 rats. H IV-1 T9 rats
showed less behavior sensitization to nicotine in comparison to F344
(Midde, Gomez et al. 2011). Both these studies suggest that that the
presence of HIV proteins in the HIV-1Tg rat altered its sensitivity to an
addictive drug. The JJ opioid receptor (MOR) which is expressed in the
central nervous system cells and in the immune system cells, may
contribute to the mediation of the analgesic and rewarding actions of
opioids such as morphine (Fowler and Fraser 1994; Chang, Beltran et al.
2007). Exposure of peritoneal macrophages of F344 rats to serum from
HIV-1Tg induced MOR-upreguJation, which was abolished by addition of
gp120 antibody to the serum (Chang. Beltran et al. 2007). HIV-1Tg rats
when treated with morphine showed significantly longer tail flick latencies
compared to control F344 rats, indicating that there is an increased potency
of morphine's anti-nociceptive properties in the HIV-1Tg rats (Chang 2011).
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As MOR is up-regulated in the HIV-1Tg rat and it has also been shown that
the anti-nociceptive properties of morphine are enhanced in the HIV-1Tg rat
we wanted to investigate if the rewarding and addictive properties of
morphine are also enhanced in the HIV-1Tg rat.
Craving for and relapse to a drug after a period of abstinence are the salient
features of addiction (Koob and Nestler 1997). In drug addiction there is a
very significant behavioral change in that that the addict has decreased
abiiity to control drug seeking behaviour(Kaiivas and Voikow 2005). in
laboratory animals relapse following abstinence is modeled using the
reinstatement procedure. Animals are first trained to associate a behavior
(self administration) or a place (CPP) with a drug. Then a period of
extinction is introduced whereby the behavior or place is no longer followed
by the drug and responding returns to baseline. The effects of various
stimuli are then introduced to look for evidence of the return of responding
or reinstatement. Reinstatement of drug seeking behavior, or relapse, is
caused in the laboratory by re-introduction to the drug (drug-primed) ,
exposure to stress (stress-primed) or re-introduction of the stimuli which
was previously associated with drug use (cue-primed) (Shalev, Grimm et al.
2002; Kalivas 2003). Re-introduction to previous stimuli/environment
associated with drug-use increases the urge to use drugs (Kalivas and
Volkow 2005). These motivational properties of the conditioned stimuli
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(associated with drug) use can persist over a very long period of time, even
after years of abstinence the conditioned stimuli can evoke drug-re
instatement (Kalivas and Volkow 2005).

Conditioned Place Preference
The conditioned place preference (CPP) is a commonly used test in
animals to measure the rewarding/addictive properties of a drug by
measuring the motivational salience of drug-paired cues, by means of
classical conditioning (Tzschentke 1998; Tzschentke 2007). In the CPP
procedure, there is repeated pairing of an unconditioned stimuli {test-drug}
with a conditioned stimulus (distinct environment) and of a control vehicle
with another environment (Tzschentke 1998). The drug-paired environment
gains motivational significance and the animal shows approach behavior to
that environment and a preference for it over the vehicle-paired
environment in the drug-free state(Tzschentke 1998). After the
establishment of a CPP the animal is given free access to both
environments for several sessions in the absence of the drug until the
animal ceases to display a statistically significant preference to the drug
paired environment (extinction)(Tzschentke 1998). Extinction is evidence
that the preference is a learned association(Rutten K 2011 }. Extinguished
associations are not permanently lost and can be re-expressed. After
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extinction exposure to a drug-prime or to a stressor can be studied for their
ability to re-instate the extinguished CPP response (Tzschentke 1998).
Reinstatement procedures cause the previous associations to be re
expressed. It has been clearly demonstrated that stress causes a greater
propensity towards drug-seeking behavior, which causes a greater chance
to become addicted (Donovan, Padin-Rivera et al. 2001; Ouimette, Coolhart
et al. 2007) and puts the subject at a greater risk for relapse (Dewart, Frank
et ai. 2006). This phenomenon has been noted in animals as well. in rats,
an increase in locomotor activity (behaviour response to drug) was noted in
morphine-treated rats pre-expose to mild repeated foot-shock(Leyton and
Stewart 1990). Exposure to foot-shock also re-instated morphine-induced
CPP in rats (Wang, Luo et al. 2000).

Conditioned Place Preference Apparatus
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Morphine-induced CPP has been studied using F344 rats (Gagin, Kook et
al. 1997; Grakalic, Schindler et al. 2006; Davis, Roma et al. 2007). There
exists a strain-based sensitivity to morphine-induced CPP; F344 rats are
more sensitive to morphine and acquire morphine-induced CPP at lower
doses and with fewer conditioning cycles than Lewis rats (Davis, Roma et
al.2007). In this study we have hypothesized that the HIV-1Tg animal
would be more sensitive to the morphine associated cues than the F344 rat
due to the up-regulation of MOR in the presence of HIV-1 proteins. As the
unbiased CPP procedure used in the present study is not favorable for
establishing differences in rates of acquisition due to potential "ceiling"
effects (Roma and Riley 2005). We investigated the difference between
HIV-1Tg and control, F344 rats, in the vulnerability to re-expression of
motivational salience of morphine paired cues by reinstatement procedures.
A greater motivational salience of morphine paired cues would be expected
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to result in greater reinstatement of a preference for the drug-paired
environment. In addition we investigated the effectiveness of a nonspecific
stressor (uncontrollable foot-shock) in establishing a reinstatement effect.
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Summary and significance ofwork:
There were an estimated 48,100 new HIV infections in 2009, per the CDC
(Prejean, Song et al. 2011) and the estimated number of people living
world-wide with HIV was 43 million in 2010, per the world health
organization {WHO}. The CDC has identified the increasing rate of HIV
infection as a major reason for the increased incidence of sepsis, in which
the patients are in a state of ET. During ET there is an imbalance of pro
and anti-inflammatory cytokine expression leading to an abnormal immune
response when re-exposed to endotoxins like LPS. We hypothesized that
the persistence of viral proteins alters the systemic immune response to
bacterial endotoxins in terms of pro- and anti-inflammatory cytokine and
chemokine expression, and that this altered immune response is
exacerbated in an endotoxin tolerant state. Specifically, we hypothesized
that the production of pro-inflammatory cytokines is diminished and anti
inflammatory cytokine production is enhanced. Taking advantage of the
HIV-1Tg rat model, we examined the effects of LPS induced endotoxin
tolerance by measuring the gene expression of 84 cytokines, chemokines
and their receptors in the brain and spleen in response to an LPS
challenge. This research will help better understand the mechanisms
underlying the increased susceptibility of HIV-1 patients to spesis. It
provides information on specific inflammatory cytokine, chemokine and their
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receptors' genes that are modulated during ET in the HIV-1Tg rat. This
information can be further used to study the inflammatory cytokine,
chemokine and their receptors' gene-profiles in other models including
humans.
Another aspect of the project was to examine the effect of morphine
associated motivational salience in the HIV-1Tg rat. Inflammatory cytokines
are known to modulate MOR expression and the progression of HIV-1
infection to AIDS. Also, MOR is upreguiated in the HIV-1Tg rat (Chang,
Beltran et al. 2007). We hypothesized that the HIV-1Tg animal would be
more sensitive to the morphine associated cues than the F344 rat due to
the up-regulation of MOR in the presence of HIV-1 proteins and altered
cytokine profiles. We investigated the difference between HIV-1Tg and
control, F344 rats, in terms of extinction of CPP and the vulnerability to re
expression of motivational salience of morphine paired cues by
reinstatement procedures. A greater motivational salience of morphine
paired cues would be expected to result in greater resistance to extinction
(Rutten K 2011) and/or greater reinstatement of a preference for the drug
paired environment. In addition we investigated the effectiveness of a
nonspecific stressor (uncontrollable foot-shock) in establishing a
reinstatement effect. This research provides salient information on
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exploring the bi-directional link that may exist between morphine-abuse and
HIV-1.
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Materials and Methods
Animals used for gene expression and protein analysis
Adolescent male Fisher 344/NHsd Sprague-Dawley background HIV-1
transgenic (HIV -1Tg) rats and age-matched Fisher INHsd 344 (F344)
control rats were purchased from Harlan Laboratories (Indianapolis, IN),
and were delivered on post-natal day 28. The animals were group-housed
immediately upon arrival, and stayed in group cages during the experiment.
The animals were maintained in an environment of controlled temperature
(21-22° C) on a 12-h Iightl12-h dark illumination cycle, with lights-on set at
7:00 AM. Food and tap water were provided ad libitum. The experimental
protocol was approved by the Institutional Animal Care and Use Committee
(IACUe) at Seton Hall University, South Orange, NJ.

Lipopolysaccharide (LPS) administration for gene expression
and protein analysis
Dosing solutions of LPS were prepared in saline. In our preliminary studies
using Harlan Sprague Dawley rats, we found that two intraperitoneal (i.p)
injections with a non-pyrogenic dose (250 IJg/kg ea) of LPS, administered 9
12 hrs apart, was the lowest dosage regimen that would cause endotoxin
tolerance and inhibit the production of IL-1J,i, TNF-a, and IL-6 in response to
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a subsequent challenge with a significantly higher dosage of lPS [1, 4, 8,
16, or 32 mg/kg] (data not shown). In this study, HIV-1Tg and F344 rats (n

=12 ea, 19-20 wks old) were randomly assigned to four experimental
groups (n =3 animals/group). At 8:00 AM and 5:00 PM on Day 1, Groups 1
and 2 received two i.p. injections of 250

~g/kg

lPS each (ll); Groups 3 and

4 received two i.p. injections of saline (SS). At 8:00 AM on Day 2, Group 1
received one Lp. injection with 5 mg/kg lPS (ll+l); Group 2 received one
Lp. injection with saline (ll+S); Group 3 received one i.p. injection with 5
mg/kg lPS (SS+L); and Group 4 received one i.p. injection with saline
(SS+S). The dosage of 5 mg/kg for the subsequent lPS injection was
chosen based on previous studies using the HIV-1Tg rat model (Chen,
Zhou et aJ. 2005). Two hours following the last injection, the brains,
spleens, and blood were collected for RNA, protein, and serum preparation.

Protein extraction from the brain and spleen
Protein extracts were prepared from approximately 100 mg of brain and
spleen tissue in a Tris lysis buffer containing 20 mM Tris, pH 7.5, 1 mM
EDTA,1 mM EGTA, and 1M NaF (all from Sigma Aldrich, St. louis, MO),
and 1 tablet of Protease Inhibitor (Roche, Mannheim, Germany). The
tissues were disrupted using the Branson Sonifier 250 (\f\NR, Radnor, PAl
with 15 sec bursts, a duty cycle setting of 40% (0.4 sec bursVO.6 sec
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pause), and an output of 4. The concentration of protein from each of the
tissue types was determined using the ProStain assay kit (Active Motif,
Carlsbad, CA), by re-suspending the lyophilized dye in methanol and dilute
this stock solution. This stock solution was added to each well of the
microplate followed by adding the sample. Fluorescence intenSity was
measured against a BSA standard curve with the Spectra Max Gemini
(Molecular Devices, Sunnyvale, CA).

Measurement ofinflammatory cytokines
Protein levels of IL-1j3, KC/GRO, IL-4, IL-5, TNF-a. IFN-y. and IL-13 were
determined in undiluted serum and in extracts from 200 I-Ig of brain and
spleen using a 96-well inflammatory cytokine kit [MesoScale Discovery
(MSD), Gaithersberg, MDl. The MSD plate is prepared per the kit
instructions
(http://www.mesoscale.com/CatalogSystemWeb/Documents/RaC96_welL
US.pdf) , the sample or calibrator are added, followed by the addition of
detection antibody solution, followed by the read buffer. Measurement of
electrochemiluminescent signal intensity was determined on the SECTOR
2400 instrument (MesoScale Discovery, Gaithersberg, MD). Calibrator
solutions were diluted 4-fold over a concentration range of 40,000 pg/mL to
9.8 pg/mL.
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RNA isolation and preparation ofeDNA
Total RNA was extracted from brain and spleen homogenates using
TRIZOL (Invitrogen, Carlsbad, CAl. The extracts were then treated with
Ambion® TURBO DNA-free TM (Ambion, Austin, TX) to remove
contaminating DNA, and harvested using a RNeasy mini kit (Qiagen,
Valencia, CAl. The tissues were disrupted and the lysate was
homogenized in the buffer, the Iysates were centrifuged the supernantant
was removed, 70% ethanol was added to the cleared lysate, sample was
transfered to an RNeasy spin column and centrifuged, wash buffer was
added followed by centrifugation
(http://www.qiagen.com/products/rnastabilizationpurification/rneasysystem/r
neasyminLaspX#Tabs=t2). RNA quality and quantity were assessed using
a Nanodrop spectrophotometer. Equal amounts of RNA from each sample
were then converted into first-strand cDNA using a RT2 First Strand Kit (SA
Biosciences, Frederick, MD). The genomic DNA elmination mixture (with
RNA sample and kit reagents) and the reverse transcription cocktail was
prepared using the kit's instructions
(http://www.sabiosciences.com/rtpcrproductlHTML/330401.html). The 2
are mixed and incubated at 42°C for 15 min afterwhich the reaction is
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stopped by heating at 95°C for 5 minutes and First Strand cDNA Synthesis
Reaction is obtained.

Real-time peR array
Detection and quantification of gene expression were performed using a
Rat Inflammatory Cytokines and Receptors PCR Array and RT2 SYBR
Green Fluorescin qPCR Master (SA Biosciences, Frederick, MD) according
to the manufacturer's instructions
(http://www.sabiosciences.com/manuals/pcrarraywhitepaper.pdf).This kit
was chosen because it includes diverse genes important in immune
responses, including genes encoding CC chemokines (n = 16), CXC
chemokines (n

=9), interleukin cytokines (n =14), other cytokines (n =11),

=15), and cytokine receptors (n =11), as well as
other genes involved in the inflammatory response (n =8).
chemokine receptors (n

Real-time PCR was performed using an ABI Prism 7900HT Fast
Detection System (Applied Biosystems, Foster, CA). Each 10 IJL reaction
was performed in a 384-well format PCR array. The PCR mix was
denatured at 95° C for 10 min before the first PCR cycle. The thermocycler
parameters were 95° C for 10 min, followed by 40 cycles at 95° C for 15 s,
and 60° C for 1 min.

40

peR array data analysis
In order to be able to compare different PCR array results, the threshold
and baseline values were set manually, according to the manufacturer's
instructions, and the resulting threshold cycle value (CT) data were
uploaded into the data analysis template on the manufacturer's website
(http://www.sabiosciences.com/pcr/arrayanalysis.php). RNA expression of
each gene was normalized using five housekeeping genes as controls. The
relative expression of each gene, compared with the expression in the
control group, was calculated on the website using the MCT method. A
difference was considered significant at p < 0.05. In the expression studies,
a gene was considered differentially regulated if the difference was >2-fold
compared with the control, and markedly differentially regulated if the
difference was >10-fold (DeRisi, Penland et al. 1996; DeRisi, Iyer et al.
1997; Linde, Sandhagen et al. 1999; Sudarsanam, Iyer et al. 2000;
Well mann, Thieblemont et al. 2000; Montgomery and Daum 2009). Each
reported value represents the mean increase or decrease of mRNA
expression relative to the levels for the controls from three biological
replicates.
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Statistical analysis o[Protein and Gene expression after LPS
treatment
Inflammatory cytokine protein level data in this study are presented as the
mean

± SO. Statistical analysis was done using Graphpad Prism 5.0.

Differences among treatment groups were analyzed by a one-way ANOVA,
followed by a Newman-Keuls post hoc test. The difference in the basal
levels of cytokineslchemokines in the brain, spleen, and serum between
F344 and HIV-1Tg rats was determined using the Student's t-test.

Animals used [or CPP
Male HIV-1 transgenic (HIV -1Tg) rats and age-matched male Fisher /NHsd
344 (F344) control rats were purchased from Harlan Laboratories
(Indianapolis, IN). Animals were group housed 4-5 per cage in ventilated
cages with a 12/12 hour day/night cycles (lights on at 7 AM) in a
temperature controlled environment (21-22°C) with food and tap water
available ad libitum. The animals were always tested in the light phase of
the day/night cycle (9AM-2PM). Animals were acclimatized for
approximately 2 months and handled for 3 consecutive days for 1-2 minutes
each before beginning testing on them. The animals were approximately 3
months old (HIV-1Tg: 193-227g; F344: 228-277 g) when the experiment
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was conducted on them. The experimental protocol was approved by the
Institutional Animal Care and Use Committee (IACUC) at Seton Hall
University, South Orange, NJ.

Drug
Morphine sulfate was obtained from (Sigma, St. Louis, MO).
Morphine was administered intra peritoneally (i.p) as a 3.5 mg/kg dosage in
the conditioning phase and as a 1mg/kg or a 3.5 mg/kg dosage in the
reinstatement phase.

cpp apparatus
A commercially available CPP apparatus (MED Associates, East
Fairfield, VT) was used. The apparatus consisted of an 18cm x 20cm white
chamber with a grid floor and an18cm x 20cm black chamber with a rail
floor connected by a side passage; this design ensures that the animal is
always visible to the camera. This side passage in the middle of the two
chambers had two doors on each chamber wall; the doors could be closed
to isolate each chamber. The animal movement and time spent in each
chamber was detected by an infrared camera (Stoelting ANY-maze, Wood
Dale, IL). ANY-maze software (Stoelting ANY-maze, Wood Dale, IL) was
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used to analyse the camera recordings to measure time spent in the each
chambers.

Foot shock administration
A custom foot-shock administrating apparatus box 40 cm w x 40 cm
d x 35 cm h, connected to an animal shocker, was purchased from Stoelting
ANY-maze (Wood dale, IL). The apparatus was set to deliver foot shock to
an animal in it intermittently, for 15 minutes, with an amplitude of 0.5 mA,
and a 0.5 s duration, (off period 10-70 s, mean 40 s).

CPP, extinction and re-instatement procedure
There were five phases for this experiment. During the
preconditioning phase (1 day), the animals were placed in the side passage
with the door of the chambers open and allowed to explore the entire box
for"15 minutes. In the conditioning phase (6 days), an approximately equal
number of animals of each strain (HIV-1Tg and F344) were assigned to
each type of chamber (white or black) as the morphine paired side. The
animals were injected with 3.5 mg/kg morphine (dose based on pilot data)
every other day and placed in the pre-assigned morphine-paired side and
on the next day were injected with equivalent volume of saline and placed
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in the saline-paired side, with the chamber door closed for 30 minutes. In
the post-conditioning phase (1 day) the rats received no drug or saline and
were placed in the side passage and allowed free access to the entire box
for 15 minutes. For the first 8 days of the extinction procedure, the animals
were put in the side passage and given free access to the box for 30
minutes. After the first 8 days of extinction (Extinction 1) testing there was
no evidence of extinction so the extinction procedure was altered in the
hope of accelerating extinction. Evidence suggests that handling and
transportation cues contribute to contextual conditioning (Bevins. McPhee
et al. 2000). thus during extinction day 9 through day 17 (Extinction 2) the
extinction procedure was repeated twice daily for 15 minutes per session
with an average interval of 2 hours and 17 minutes between the 2 sessions,
to increase the number of exposures to the transportation cues without
changing the duration of exposure to the context (30 minutes total).
Dividing the extinction procedure into two separate sessions also permitted
for the opportunity of spontaneous recovery (see Discussion). Moreover.
the HIV-1Tg rats received 3 additional days of extinction (see Results).
Following extinction the rats in each strain were distributed equally to either
be assigned in the drug-induced reinstatement group or in the stress
induced reinstatement group. The rats in the drug-induced reinstatement
group received 1mg/kg morphine on reinstatement day 1 and were given
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free access to the entire box for 15 minutes; on re-instatement day 2 the
rats were given 3.5 mg/kg morphine and were given free access to the
entire box for 15 minutes. The rats in the stress-induced re-instatement
group on day 2 of the re-instatement phase were administered foot-shock
for 15 minutes and subsequently put in the CPP apparatus and given free
access to the entire box for 15 minutes.
The movement of the rats in the CPP apparatus was tracked by the
ANY-maze camera and software in all phases. The experiment was carried
out daily.

Statistical Analysis
The means and standard deviations of the absolute time spent by
animals (for each strain) in each chamber were calculated in all phases of
the experiment. Inspection of the extinction data indicated that the chamber
that was paired with morphine had a substantial effect on preference
behaviour. To evaluate the effect of color/flooring of the chambers on the
acquisition and extinction of CPP the data was analysed with color of the
morphine-paired chamber as a factor. Careful inspection of the data also
revealed systematic changes in preference within a test session suggesting
that there was habituation of exploratory behaviour over time. To test this
hypothesis the extinction sessions were separated into segments of five
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minutes. Analysis of variance (AN OVA) was used to study the interaction
of strain (F344, HIV-1Tg), phase (pre-conditioning, post-conditioning,
extinction 1 and2, and/or reinstatement), morphine-paired chamber, drug
(morphine-paired, saline-paired). A value of p :::;;0.05 was considered
statistically significant difference.
All analyses were done using the statistical software SPSS
Statistics 17.0 IBM).
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Results
Cytokine and chemokine protein expression in the serum, brain,
and spleen ofHIV-1 Tg rats during endotoxin tolerance (ET)
The protein levels of IL-1~, KC/GRO, IL-4, IL-5, TNF-a, IFN-y, and IL-13
were determined in the brain, spleen, and sera of HIV-1Tg and F344 rats
rendered ET (LL), then challenged with either LPS (LL +L) or saline (LL +S),
using an electrochemiluminescent (MSD) assay (Table 1-3). Saline-treated
animals were used as controls (SS+S). There was no difference in the
basal levels (SS+S group levels) of the cytokines/chemokines measured in
the serum in the two strains of animals (Table 1). In the F344 serum, the
levels of the pro-inflammatory cytokine, IFN-y, and the anti-inflammatory
cytokines, IL-4 and IL-13, in the single exposure group (SS+L) were
significantly greater than in the control group (SS+S), and significantly less
in the ET group (LL +L) than in the single exposure group (SS+L). In the
HIV-1Tg serum, the levels of the pro-inflammatory cytokines,

JL-1~,

TNF-a,

and IFN-y, and the anti-inflammatory cytokines. IL-4 and IL-13, in the single
exposure group (SS+L) were significantly higher than in the control group
(SS+S), and significantly lower in the ET group (LL +L) than in the single
exposure group (SS+L) [fable 1].
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Table 1: Cytokine/Chemokine Profiles in F344 and HIV-1Tg Rat Serum

Cytokines and Chemo~nes in the Serum with LPS Treatment
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F344 n=12, 3 in each group; HIV-1Tg n=12. 3 in each group

The basal levels of IL-4 and TNF-a in the F344 rat brain, and IL-4, IL-5,
and TNF-a in the HIV1-Tg brain, were not detectable by
electrochemiluminescent (MSD) assay. The basal levels of
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cytokines/chemokines that were detectable in the brain were similar in both
strains of animals (Table 2). An LPS challenge dose (SS+L and LL+L) did
not significantly alter any of the cytokine/chemokine levels in the F344 rat
brain (Table 2). However, in the HIV-'ITg rat brain, the levels of the pro
inflammatory cytokines, IL-113 and IFN-y, were significantly higher in the
SS+L group versus the control. The level of the pro-inflammatory cytokine,
IFN-y, was significantly lower in the LL +L group compared to the SS+L

group (Table 2).
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Table 2: Cytokine/Chemokine Profiles in the F344 and HIV-1Tg Rat Brain

Cytokines and Chemokines in the Brain with lPS Treatrnent
Proteillpghnr-SD)
l·1p

KCJGRO

l-4

tieIWilllwJta

l·13

nteret.m4

ttrerm5

m·afiIa

~gamma

Werm13

15.~±7.5l

4.~i1.8)

42.2(f8.8)

74.~±23.3)

N)

$.~±)

NO

178.~±162.1)

1325.~±1431.3)

l3.~

102.~±61.1)

30.9

2O~±11.9)

4.B1±3.1)

59.11±26·3)

3.4

74.7

14.1(±7.0)

6.~±1.4)

207.~±133.0)

112.6(f35.6)
10li~±685.6)

If)

2.~±1.~

141.~f98.3)

NO

21.~±6.~

5.~±2.3)

l·lp

KCJGRO

l-4

l·5

TNF-a

FN-y

l·13
i1ereukil13
5.l(fOA)

:

TlIIlOfrem~

HW·1Tg
tieIWilllwJta

SStS
SS+L
LLtS
Ll+L

FN-y

TIm~

F344

SStS
SS+l
lltS
LLtl

N-a

loS

Werm4

ttrerm5

fa:1Of •afiIa

rereron gamma

NO

11.7(±5.2)
47.11±1(5)*

37.~i17.l)

125.~f87.a)

N)

N)

361.7(±104.'

2991.31±491.~1i

9.~±3.1)

164~±35.3)

$.~±15.1l

12B.l(±61.6)

N)

NO

NO

8.~±5.~

4.~i1.4)

208.~±167.4)

131~±10391)A

18121±50·0)

27.3

24.31±14.5jA

7.~±3.71

a.ll±1.6)

.5

9.~±411

• P<O.05, •• P<O.OI, .... P<O.OOI greateT SS+S control;" P<O.05, AI' P<O.OI, """ P<O.OOI less than SS+L
F344 n=12, 3 in each group; HIV-Hg n=12, 3 in each group

The basal level of TNF-a was not detectable in the spleen of either the
F344 or HIV1-Tg rats (Table 3). There was no Significant difference in the
basal levels of any of the cytokines/chemokines that were detectable in the
spleen of the F344 and HIV-1Tg rats, with the exception of IFN-y, which
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was significantly greater in the F344 rat spleen compared to that in the HIV
1Tg rat spleen (Table 3). In the F344 spleen, the levels of the pro
inflammatory cytokines, IL-1 J3 and IFN-y. and the anti-inflammatory
cytokines, IL-4 and IL-13. in the single exposure group (SS+L) were
significantly higher than in the control. In the F344 rats, the levels of the
pro-inflammatory cytokines, IL-1 J3 and IFN-y, and the anti-inflammatory
cytokine, IL-4, were significantly lower in the spleen of the LL +L group
compared to the single exposure group (SS+L). In the HIV-1Tg spleen, the
levels of the

pro-in'l~ammatory

cytokines, IL-1 J3 and IFN-y, and the anti

inflammatory cytokine. IL-4, were significantly higher in the single exposure
group (SS+L) and in the endotoxin tolerant group (LL+L) compared to the
control. In the LL+L group of HIV-1Tg rats, the pro-inflammatory cytokines,
IL-1 J3 and IFN-y. and the anti-inflammatory cytokine, IL-4, were significantly
lower than in the single exposure (SS+L) group (Table 3).
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Table 3: Cytokine/Chemokine Profiles in the F344 and HIV-1Tg Rat Spleen
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Expression profiles ofcytokines, cytokine-receptors, and other
inflammatory molecules in the brain and spleen ofthe HIV-l Tg
rat following LPS treatment
The gene expression profiles of an array of cytokines, cytokine receptors,
and other inflammatory molecules were determined in the brain and spleen
of the three LPS treatment groups (SS+L, LL +S, and LL +L) and compared
to the control group (SS+S) of both the HIV-1Tg and F344 rats (Figure-1).
In the F344 and HIV-1Tg rat brain, the level of the pro-inflammatory
cytokine, IL-1J3, was elevated in the LL+L (>9 fold) and SS+L (>4 fold)
groups. The level of the anti-inflammatory cytokine, IL-10, was elevated in
the brain of both the SS+L (>3 fold) and LL +L (>2 fold) groups in the F344
rats, but only in the brain of the SS+L (>2 fold) group in the HIV-1Tg rat
brain (Figure-1). In the spleen of the F344 and HIV-1Tg rats, the levels of
the pro-inflammatory cytokines, IL-1a, IL-1J3, were elevated in both the
SS+L (>10 fold) and LL +L (>5 fold) groups. The levels of the pro
inflammatory cytokines, IFN-y and TNF-a, were increased in the SS+L
group (>6 fold), and the anti-inflammatory cytokine, IL-10, was higher in the
SS+L (> 5 fold) and LL+L (>7 fold) groups (Table-4).
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Table 4: Cytokine Expression in the Brain and Spleen of F344 and HIV-1Tg Rats
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F344 n=12, 3 in each group; HlY-1Tg n=12, 31n eachgroupEXpression profiles of
chemokine and chemokine receptors in the brain and spleen of
the HIV-l Tg ratfollowing LPS treatment
The gene expression profiles of various chemokines and chemokine
receptors were examined in the three LPS treatment groups and compared
to the control group (SS+S) in both the HIV-1Tg and F344 rats (Figure-2).
The gene expression of the inflammatory cc chemokines, Ccl2, Ccl3, Ccl?,
and Cc120, and inflammatory Cxc chemokines, Cxcl1, Cxcl2, and Cxcl1 0,
were up-regulated in the brain and spleen in the SS+L and LL +L groups of
both the F344 and HIV-'ITg rats. The gene expression of the inflammatory
cc chemokines, Ccl11 and Ccl24, were down-regulated in the brain of the
LL+L group of both the F344 and HIV-1Tg rats, and in the SS+L and LL+L
groups in the spleen of the HIV-1Tg rats.
Ten of the 15 (10/15) chemokine receptors studied were down-regulated
in the LL+L group of'the spleen of the F344 rats. One of 15 (1/15) and
three of 15 (3/15) chemokine receptors were down-regulated in the LL +L
group of the brain of the F344 and HIV-1Tg rats, respectively; ten of 15

(10/15) and two of 15 (2/15) chemokine receptors were diminished in the
LL+L group of the spleen of the F344 and HIV-1Tg rats (Figure-2).
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Table 5: Chemokine Expression in the Brain and Spleen of F344 and HIV-1Tg Rats

F344 n=12, 3 in each group; HIV-1Tg n=12, 3 in each group
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Morphine-induced place preference
Fourteen HIV-1Tg and 14 F344 rats were placed in the CPP apparatus and
given free access for 15 minutes (pre-conditioning) to determine if either
strain showed a preference for one of the chambers. As shown in Figure 1
neither the HIV-1Tg rats nor the F344 rats showed a preference for either
the black or white chambers in the pre-conditioning phase. After 6 sessions
of conditioning with 3.5 mg/kg morphine, both HIV-1Tg and F344 rats
showed a CPP (Figure 1). A Strain (F344, HIV-1 Tg) x Phase (Pre, Post) x
Drug (Morphine-Paired, Saline-Paired) mixed ANOVA yielded a significant
Phase x Side interaction F(1,26)

=31.03, P =.000 • such that more time

was spent in the morphine-paired side than in the saline-paired side post
conditioning but not pre-conditioning.
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Figure 1: Time spent in the morphine-paired and saline-paired side of the CPP
apparatus by strain in pre-conditioning and post-conditioning phase is shown. On
post-conditioning day animals (F344 n=14; HIV.1Tg n=14) were conditioned daily for
15 minutes following a 3.5mg/kg morphine (i.p.) dose every other day for 6 days. The
following day after 6 conditioning sessions, animals were given free access to entire
apparatus and tested for CPP.
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To counterbalance for the morphine/side pairings, the strains were divided
so that approximately half received morphine paired with the black side and
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the remainder received morphine paired with the white side. In addition to
the color difference, the two sides also had different floors (grid and rail).
Since the rats were tested under dim red-light illumination the floor was a
much more salient cue than the color, eliminating a natural bias for the
black chambers (Roma and Riley 2005). Nevertheless, for convenience the
sides are referred to as black or white. The absence of a side preference
during the 15 min pre-conditioning session suggested that the CPP
apparatus used in this study was an unbiased apparatus. However after
introducing the extinction procedure it was observed that there was a very
high resistance to extinction in many animals. Inspection of the data
indicated a stronger preference during extinction in the white-morphine
paired animals than the black-morphine paired animals. Thus, to confirm
that a CPP occurred in the white-paired and black-paired animals the data
was analyzed with the counterbalancing factor (color of morphine-paired
chamber) included as an independent variable (Figure 2). A Strain (F344,
HIV-1Tg) x Phase (Pre, Post) x Morphine Color (Black, White) x Drug
(Morphine-Paired. Saline-Paired) mixed ANOVA yielded a significant four
way interaction, F(1,24)

=4.59, p =.043, that was due to a greater CPP

when morphine was paired with the white side in the F344 animals [Phase x
Drug x Morphine Color: F(1, 12) = 7.54, P =.018] but not the HIV-1Tg rats.
In the HIV-1Tg rats the significant CPP (Phase x Drug: F(1.12)
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=20.83, p =

.001) was not affected by the color of the morphine-paired chamber [Phase
x Drug x Morphine Color: F(1,12) < 1, p

=.784] (Figure 2).

Figure 2: Time spent in the morphine-paired and saline-paired side of the CPP
apparatus by strain and by color of morphine-paired chamber, in pre-conditioning
and post-conditioning phase is shown. (F344 n=14; HIV-1Tg n=14).
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To investigate further the effect of time on the development of CPP we
analysed the data in segments of 5-minutes. Figure 3 shows the pre
conditioning and post-conditioning results separated into three 5-minute

61

time segments. The rats were again divided in tenns of the side that was
paired with the drug (color of morphine-paired chamber). When the pre
conditioning data were analysed, no statistically significant effects were
observed. However, the post-conditioning data shows clear changes in
preference over the three, 5-minute periods. A Strain (F344, HIV-1Tg) x
Phase (Pre, Post) x Morphine Color (Black. White) x Drug (Morphine
Paired, Saline-Paired) mixed ANOVA confinned a 4- way interaction
F(2,48)

=4.27, p =.02. Generally, the rats engaged in considerable

exploratory behaviour often crossing between chambers, but as time
passed rats explored less and spent more time on the morphine-paired
side. This can be seen in the black-paired and white-paired HIV-1Tg
groups (bottom graph). Although this pattern of increasing preference over
time was not seen in the black-paired F344 group it was very pronounced in
the white-paired F344 rats (top graph). When the animals were first placed
in the CPP apparatus they explored and might have spent more time
exploring in the preferred sides, but as the exploratory behaviour habituates
the time spent in the preferred side increases even more. The data
suggests that the F344 rats that experienced morphine paired with the
white side had the strongest preference for the morphine-paired side
(Figure 3).
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Figure 3: Time spent in the morphine-paired and saline-paired side of the CPP
apparatus by strain and by color of morphine-paired chamber separated into three 5
minute time segments, in pre-conditioning and post-conditioning phase is shown.
(F344 n=14; HIV-1Tg n=14)
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Extinction
To test for extinction (no difference in time spent in the morphine-paired
side and saline-paired side) animals were given free access to the both
chambers for 30 minutes per day for 8 days (Extinction 1) and for 2
sessions of 15 minutes per day thereafter (Extinction 2a and 2b).
The time spent in the morphine-paired side in 5-minute time segments for
two phases of extinction is shown in Figure 4. A score of 150 indicates
equal time spent in the black and white chambers per time segment (no
preference); a score greater than 150 indicates a preference for the
morphine-paired side. The average across all days for each extinction
phase is plotted in order to show the high resistance to extinction in the rats
that experienced morphine paired with the white chamber and to
demonstrate the observed within-session changes in preference. We
hypothesize that the within-session increase in preference is due to
habituation of exploratory behaviour in the presence of a highly preferred
white chamber. Evidence consistent with this habituation interpretation is
provided in Extinction 2 where spontaneous recovery of exploratory
behaviour was observed as a result of the delay between Extinction 2a and
2b (Figure 4). These results suggest that the rats had a natural preference
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for the white side that was not evident in the preconditioning phase, but
when paired with morphine it became a much stronger preference that was
highly resistant to extinction.
Figure 4: Extinction phase: To test for extinction, animals (F344 (n=14), HIV-1Tg
(n=14» were given free access to the entire apparatus for 30 mlns (F344: 8 days,
HIV-1Tg: 8 days) everyday (Extinction 1) and then for 2 fifteen min sessions/day
(F344:9 days, HIV-1Tg: 13 days) (Extinction 2a and 2b) until all animals reach
extinction. Average time spent in the morphine-paired side by strain and by color of
morphine-paired chamber separated into three 5-minute time segments (group
means) in the 2 phases of extinction (Extinction 1 and Extinction 2 (a and b» is
shown.
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If habituation of exploratory behaviour contributes to the increasing
preference over time in the CPP test, as hypothesized here, then the
preference at the beginning of Extinction 2b (minutes 16-20) should be less
than the preference observed at the end of Extinction 2a (minutes 10-15)
because the delay causes the spontaneous recovery of exploratory
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behaviour. This is the pattern seen in the Extinction 2 data of the white
morphine paired groups that are plotted in Figure 4. Note that this drop in
preference between minutes 10-15 and minutes 16-20 is not seen in
Extinction 1 since there was no delay imposed between these time
segments to allow for spontaneous recovery of exploratory behaviour. To
confirm these observations a spontaneous recovery score was calculated
for all rats by subtracting the time spent on the morphine-paired side during
the fourth time segment (minutes 16-20) from the time spent on the
morphine-paired side during third time segment (minutes 11-15). A positive
score indicates spontaneous recovery, whereas a negative score indicates
continued habituation. To facilitate statistical analysis of Extinction 1 (which
had 8 days) and Extinction 2 (which had 9 days), the last day of extinction 2
was omitted. The data was then analyzed with a Strain (2) x Morphine
Color (2) x Extinction Phase (2) by Days (8) mixed ANOVA. The white
morphine paired and black-morphine paired HIV-1Tg and F344 groups
averaged across days for the two extinctions sessions are shown in Figure
5. Spontaneous recovery was observed in the white-morphine paired
groups (right panel) in Extinction 2, when a delay was present, but not in
Extinction 1 when there was no delay. These observations were supported
by a significant main effect of Extinction Phase, F(1 ,24)

=17.3, P =.000.

A

significant main effect of color of morphine-paired chamber, F(1 ,24) = 6,14,

67

p = .021 , supports the impression that spontaneous recovery was greater in
the white-morphine paired groups than the black-morphine paired groups.
There was no significant effect of days. The results also suggest that
spontaneous recovery was greater in the F344 rats than the HIV-1Tg rats,
but the main effect of strain fell short of significance, F(1, 24)
and strain did not interact with any other factor.

68

=3.29, p =.08

Figure 5: Spontaneous Recovery Score- The time spent on the morphine-paired side
during the 4th time segment (minutes 16-20) was subtracted from the time spent on
the morphine-paired side during third time segment (minutes 11-15). A positive
score indicates spontaneous recovery, whereas a negative score indicates
continued habituation. The results for the white-morphine paired and blackmorphine paired HIV-1 and F344 groups averaged across days for the two
extinctions sessions are shown below. To facilitate statistical analysis of Extinction
1 (which had 8 days) and Extinction 2 (which had 9 days), the last day of extinction 2
was omitted. (F344 n=14; HIV-1Tg n=14)
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These pattern of data suggest that during a CPP test there are several
factors that influence overall behaviour: a conditioned place preference, a
natural preference (when present), and the elicitation of exploratory
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behaviour that interacts with the conditioned and natural preferences. The
impact of the two preferences on performance differs across a session as
exploratory behaviour undergoes habituation, with the stronger preference
dominating control of behaviour later in a session as the rats begin to "settle
into" one chamber. Whereas a strong natural preference for one side may
obscure a more modest conditioned place preference later in a session, the
conditioned place preference may have a greater contributing role in overall
performance earlier in a session when exploratory behaviour is at its
maximum. We suggest that the strong preference for the white chamber in
the rats that received the white side paired with morphine is a result of an
enhanced natural preference for the white side rather than a result of the
summation of a conditioned place preference with a natural preference. If
the latter was true, then preference in the first 5 minutes of an extinction
session (when a modest CPP is having its greatest impact on performance)
should decline over days as the CPP undergoes extinction, whereas the
preference later in a session (which reflects the stronger natural preference)
should persist over days. However, if morphine induced the enhancement
of a natural preference that is resistant to extinction, then the observed
preference should be seen at all time intervals across all days with no
evidence of extinction. The time in the morphine- and saline-paired sides of
the F344 animals that received morphine paired with the white side is
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shown over days for two of the six 5-minute time segments in Figure 6. A
preference for the morphine-paired side in the first 5 minutes (top panels) is
observed that does not change over days in Extinction 1, [Effect of Drug:
F(1 ,5) = 63.62, P =.000; Drug x Days: F(7, 35) < 1, n.s.], or in Extinction 2
[Effect of Drug: F(1 ,5) = 28.27, P =.003; Drug x Days: F(8, 40) = 1.34, P =
.251]. Thus, there is no evidence of extinction over days, even when just
the first 5 minutes, when a CPP is likely to have its greatest impact, are
examined. By the fourth time segment (minutes 16-20) of Extinction 1 the
preference for the morphine-paired time is even greater (bottom, left panel)
as exploratory behaviour begins to habituate. However, during Extinction 2,
when the 16 - 20 minute time segment was preceded by a break, the
preference is again reduced as exploratory behaviour spontaneously
recovers. Yet there is still no indication of a decreased preference for the
morphine-paired side over days, [Drug x Days: F(8, 40) = 1.73, P =.121].
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Figure 6: The time spent in the morphine- and saline-paired sides over days of the F344 animals that
received morphine paired with the white side. The Extinction 1 graphs are shown on the left side and
Extinction 2 are shown on the right. Data from only 2 of the 6 time segments are shown The top
graphs show the first time segment (minutes 1 - 5) and the lower graphs show the fourth time
segment (minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded by a break
from the previous session to allow for spontaneous recovery of exploratory behavior. (F344 rats with
morphine paired with white side n=7).
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The same pattern is also seen in the HIV-1Tg rats (Figure 7).
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Figure 7: The time spent in the morphine- and saline-paired sides over days of the
HIV-1Tg animals that received morphine paired with the white side. The Extinction 1
graphs are shown on the left side and Extinction 2 are shown on the right. Data
from only 2 of the 6 time segments are shown. The top graphs show the first time
segment (minutes 1 - 5) and the lower graphs show the fourth time segment
(minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded
by a break from the previous session to allow for spontaneous recovery of
exploratory behavior. (HIV-1Tg rats with morphine paired with white side n=7).
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The pattern of results for the rats that received morphine paired with the
black side was very different. Figures 8 and 9 show the data for the F344
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and the HIV-1Tg rats respectively. These were plotted in the same manner
as the previous graphs. The Extinction 1 and 2 data were analysed
separately with a Strain (2) x Drug (2) x Days (8 or 9) mixed ANOVA.
During the first 5 minutes of Extinction 1 there was a significant preference
for the morphine-paired side that persisted across days of Extinction 1 in
both strains [Main Effect of Drug: F(1.12)

=6.32, P =.027; Drug x Days:

F(7.84) < 1. n.s.]. There were no significant effects of strain. By Extinction
2 the main effect of Drug was no longer significant [F (1,12) < 1. n.s.]·
indicating the extinction of a CPP. Once again there were no significant
effects of strain.
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Figure 8: The time spent in the morphine- and saline-paired sides over days of the
F344 animals that received morphine paired with the black side. The Extinction 1
graphs are shown on the left side and Extinction 2 are shown on the right. Data
from only 2 of the 6 time segments are shown. The top graphs show the first time
segment (minutes 1 - 5) and the lower graphs show the fourth time segment
(minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded
by a break from the previous session to allow for spontaneous recovery of
exploratory behavior. (F344 rats with morphine-paired with black side n=7)
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During the fourth time segment (minutes 16-20) a reversal in preference
from the black morphine-paired side to the white saline-paired side took
place during Extinction 2 in the F344 rats (Figure 8) [F(7, 49)
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=2.41, p =

.034]. The absence of a significant preference during the 16-20 minute time
segment of Extinction 1 may reflect the persistence of a conditioned
preference for the black chamber that competed with the natural preference
for the white chamber. By extinction 2 the extinguished CPP no longer
competed with the natural preference, reversing the side preference. This
reversal during minutes 16 - 20 in Extinction 2 was not observed in the
HIV-'ITg rats [F(7,35) < 1, n.s.] (Figure 9), however, suggesting that CPP
was not fully extinguished in the HIV-1Tg rats. Thus, the HIV-1Tg rats were
tested for 3 additional days for extinction.
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Figure 9: The time spent in the morphine- and saline-paired sides over days of the
HIV-1Tg animals that received morphine paired with the black side. The Extinction 1
graphs are shown on the left side and Extinction 2 are shown on the right. Data
from only 2 of the 6 time segments are shown. The top graphs show the first time
segment (minutes 1 - 5) and the lower graphs show the fourth time segment
(minutes 16-20). During Extinction 2 the 16-20 minute time segment was preceded
by a break from the previous session to allow for spontaneous recovery of
exploratory behavior. (HIV-1Tg rats with morphine paired with black side n=7).
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Figure 10 shows the results of the last three extinction days for the
HIV-1Tg rats. There was no effect of days; therefore the means across all
three days were presented. A Significant four-way interaction was found
F(4,48)

=3.39, P =.016.

The rats for whom morphine was paired with the
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white side (top graph) continued to show a significant preference for the
morphine-paired side at all time segments and the preference increased
across the first session as well as across the second session after
spontaneous recovery of exploratory behaviour. The rats for whom
morphine was paired with the black side (lower graph) did not show a
preference during the first time segments of both extinction sessions (time
segments 1-5 and 16-20) but showed a reverse preference in the
subsequent sessions. Thus, although a reverse preference was not
observed in the first five minutes of extinction like in the F344 rats, the
strong preference for the saline-paired side later in the sessions is
consistent with the suggestion that the white chamber is a highly preferred
chamber that was not evident in preconditioning test.
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Figure 10 - Time in Morphine-paired chamber over time segments for HIV-1Tg rats
given three additional days of extinction during the second extinction
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30

Reinstatement with re-introduction o/morphine
F344 (n=7) and HIV-1Tg (n=7) after reaching the extinction state were
given 1mg/kg morphine and tested for CPP by giving them free access to
the entire apparatus for 15 minutes. On the next day the same animals
were given a higher dose of morphine (3.5 mg/kg, Lp.) and then free access
to the entire apparatus for 15 minutes. The HIV-1Tg and F344 animals that
had morphine paired with the black side showed a preference for the saline
paired side during the reinstatement test. This supports the argument that
the rats had a natural preference for the white side that was counteracted
by the CPP, but when the CPP is extinguished the animals chose to spend
more time on the white side during all three time segments despite the
reinstatement attempt. The data from the HIV-1Tg and F344 rats that had
the morphine paired with the white side simply confirms that they had a
preference for the white side. It cannot be assumed that this preference is
a reinstatement effect because they never extinguished this preference
during the extinction phase.
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Reinstatement with a foot shock stressor.
After reaching extinction the F344 (n=7) and HIV-1Tg (n=7) were
administered a foot-shock for 15 min. intermittently and the tested for CPP
by giving them free access to the entire apparatus for 15 min. The F344
and HIV-1Tg rats that had the morphine paired with the white side showed
a preference for the white chamber that increases across the time
segments (Tim Seg x Drug: F344, F(2,4) = 29.245, = .004; HIV-1Tg, F(2, 6)
= 7.773, P

=.022).

These groups, of course, cannot be used to assess

reinstatement because their preference for white never extinguished, but it
does confirm that the white preference in the white-morphine paired groups
observed throughout extinction is still present. However, no statistically
significant effects were observed in the F344 or HIV-1Tg rats that had
morphine paired with the black side.
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Discussion
Endotoxin tolerance (ET) is a phenomenon in which previous exposure of
cells or organisms to microbial products, such as the endotoxin, LPS,
induces a transient period of hypo-responsiveness to a subsequent
endotoxin challenge. Exposure to an endotoxin initiates the production of
pro-inflammatory cytokines and a subsequent production of anti
inflammatory cytokines by immune cells (Foster, Hargreaves et a!. 2007;
Mages, Dietrich et a!. 2007; del Fresno, Garcia-Rio et al. 2009; Draisma,
Pickkers et al. 2009). ET is characterized by diminished release of pro
inflammatory cytokines, such as IL-1J3, IL-10, and TNF-a, and increased
expression of anti-inflammatory cytokines, such as IL-10 (Biswas, Bist et al.
2007). This negative feedback mechanism is important for protecting the
host from tissue damage and death caused by excessive inflammation.
The differential expression of cytokines/chemokines in different tissues and
at different times has been examined in Sprague Dawley rats to investigate
the modulation of immune responses (Chen, Zhou et al. 2005).
The occurrence of ET has been shown to increase the incidence of
several diseases, including sepsis, pancreatitis, trauma and surgery
(Biswas and Lopez-Collazo 2009). The CDC has identified the increase of
HIV-1 positive population as a major factor in the increased incidence of
sepsis(Angus, Linde-Zwirble et al. 2001). Studies have shown that the
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presence of HIV viral proteins causes a compromised immune response in
HIV-1 patients (Capobianchi 1996; Schols and De Clercq 1996; Wilson,
Habeshaw et al. 1997; Herbeuval and Shearer 2006; Boasso, Shearer et al.
2009). The phenomenon of ET during HIV-1 infection has not been
studied through animal models. Reid and colleagues (Reid, Sadowska et
al. 2001) established a non-infectious HIV-1 transgenic (HIV-1Tg) rat model
that expresses an HIV-1 provirus regulated by the viral promoter, but with a
functional deletion of gag and pol. The characteristics of the HIV-1Tg rat
include immunologic dysfunction, nephropathy, muscle wasting, skin
lesions, and cataracts. We studied the systemic effect of the concurrent
presence HIV-1 viral proteins and ET on the inflammatory response to
bacterial endotoxin using the HIV-1Tg rat model. We examined the LPS
induced gene expression of 84 cytokines, chemokines, and their receptors
in the blood, brain, and spleen of the endotoxin tolerant HIV-1Tg rat. Based
on previous studies, we used two injections of a low dose of LPS (250
IJg/kg) administered 9 h apart to induce ET, and a challenge injection with a
high dose of LPS (5 mg/kg) 12 h later. A single exposure to a high dose of
endotoxin should cause a significant increase in the levels of pro
innammatory and anti-inflammatory cytokines compared to control (Chen,
Zhou et al. 2005). In the ET state, when animals are exposed to repeated
low doses of endotoxin, upon a subsequent challenge with a high dose of
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the endotoxin, one would expect that the increase in the pro-inflammatory
cytokine levels would be lower compared to that in the single high dose
exposure group (Biswas, Bist et al. 2007). To confirm that the animals
were in the ET state, we measured the protein levels of inflammatory
cytokines after the LPS challenge dose. Although the basal levels in the
brain, spleen, and serum of the control groups (SS+S) of F344 and HIV-1Tg
rats were similar, the changes in the cytokine and chemokine profiles in
response to LPS were different in the HIV-1Tg and F344 rats. We found
that, during ET, there was a significantly diminished expression of pro
inflammatory cytokines, such as

IL-1~,

IFN-y, and TNF-a, in response to

LPS (LL +L) compared to a single exposure of LPS (SS+L).
Of particular interest was the finding that the basal level of IFN-y in the
spleen was lower in the SS+S group of HIV-1Tg rats than of the F344 rats,
but was significantly increased in the SS+L and LL+L groups of the HIV-1 Tg
rats compared to the F344 rats (Table 3). A recent study showed that IFN-y
countered ET by facilitating Toll-like receptor (TLR)-induced chromatin
remodeling (Chen and Ivashkiv 2010). ET was prevented in IFN-y pre
treated primary human monocytes, and production of pro-inflammatory
cytokines, such as TNF-a and IL-6, was restored by facilitating TLR-induced
chromatin remodeling (Chen and Ivashkiv 2010). It would be interesting to
examine what role IFN-y plays in the restoration of the production of pro
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inflammatory cytokines at the transcriptional level in the HIV-1Tg rat
compared to control.
We found that, in both the ET state and after a single exposure to LPS.
there was an altered response to LPS in terms of pro-inflammatory cytokine
production in the spleen of the HIV-1Tg rats compared to the F344 rats.
The expression level of the pro-inflammatory cytokines, IL-1a, IL-1 J3, and
IFN-y, was 4- to 82-fold greater in the spleen of the HIV-1Tg rats compared
to the F344 rats in both the single LPS exposure (SS+L) and ET (LL+L)
groups, indicating that the presence of viral proteins may have an effect on
innate immune responses. There was also a difference in the expression of
cytokine receptors in the brain of the HIV-1Tg rats compared to the F344
rats in response to LPS in both the ET state and after a single exposure to
LPS, suggesting that HIV-1 viral proteins may interact with or work through
cytokine receptors in the brain. These data warrant further investigation
into the neuroimmune effects of HIV-1 viral proteins.
Studies show that there is an alteration of cytokine receptors in the brain
during HIV infection(Masliah, Ge et al. 1994) and that there is an
association of IL2Ralpha, IL4Ralpha, IL 10Ralpha, and IFN (gamma) R1
cytokine receptor genes with AIDS progression(Do, Vasilescu et al. 2006)
and that cytokine receptor deficiencies may contribute to immune deficiency
in HIV-infected patients (Pahwa 2007). Sirskyj D and colleagues
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comprehensively review the effects of the disruption of the
cytokine/cytokine receptor network in T-cells during HIV infection(Sirskyj,
Theze et al. 2008). However, the molecular mechanisms causing this are
largely unknown, due to the due to the incredibly complex interplay between
viral factors and host cytokine signaling pathways (Sirskyj, Theze et al.
2008).
During ET, the production of pro-inflammatory cytokines, such as IL-1J3,
IL-4, and IL-5, in response to LPS (LL +L) was diminished in contrast to that
elicited by a single exposure to the endotoxin (SS+L). This altered
response was seen in the spleen and serum in both the HIV-1Tg and F344
ET rats.
The spleen is an immune system organ, and, as such, one would expect
that a greater number of cytokine and chemokine genes would be changed
in the spleen in response to an immune challenge compared to the brain,
and that is what we found in this study. In both the HIV-1Tg and F344 rats,
there was a greater response to LPS in the spleen than in the brain.
Chemokines and their receptors have been implicated in the
neuropathogenesis of HIV-1 infection (Mahajan, Schwartz et al. 2002).
There were significant differences in chemokine expression in response to
LPS in the HIV-1Tg rats compared to the F344 rats. Enhanced levels of
Ccl2 in HIV-1 patients have been associated with HIV-1-associated
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dementia (Ansari, Heiken et al. 2007). Our results indicate that Ccl2 levels
were increased to a greater extent (3- to 5-fold) in the brain of the SS+L
and LL+L groups of HIV-1Tg rats versus the F344 rats, corroborating the
role of upregulation of Ccl2 and its implications on HIVencephalopathy.
The levels of the inflammatory CXC chemokines, Cxcl1, Cxcl2, Cxcl10, and
Cxcl11, were elevated to a greater extent (0.1- to 40-fold) in the brain of the
SS+L and LL+L groups of the F344 rats compared to the HIV-1Tg rats.
Ccl2, Ccl7, and Ccl9,levels were increased to a greater extent in the SS+L
and LL +L groups of the spleen of the HIV-1 Tg rats in comparison to the
F344 rats. Cxcl1 and Cxcl2 levels were elevated to a lesser extent in the
spleen of the SS+L and LL +L groups of the F344 rats compared to the HIV
1Tg rats.
Chemokines and chemokine receptors define a network throughout the
body, playing critical roles in immune and inflammatory responses as well
as in many pathological processes, in diseases such as multiple sclerosis,
Alzheimer's disease, and HIV/AIDS (Martin-Garcia, Kolson et al. 2002).
Cxcr4 and Ccr5 are reported to be co-receptors that mediate HIV-1 entry
(8achis, Cruz et al. 2010).

In our study, the gene expression of the

chemokine receptors, Ccr2, Ccr3, Ccr4, Ccr5, Ccr7, Cxcr3, Ccr10, Ccr3,
Cx3cr1, IL-BrJ3, and Xcr1, in the spleen of the ET group (LL +L) of F344 rats
were down-regulated, whereas those in the HIV-1Tg spleen were not
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significantly different compared to the control group (SS+S). All these
receptors have been shown to function as co-receptors for HIV-1infection

in vitro (Starr-Spires and Collman 2002), which suggests that HIV-1 viral
proteins may interact with these chemokine receptors in vivo. There is also
evidence that chemokines and chemokine receptors play an important part
in the signaling of neuroprotective effects in the brain (Martin-Garcia,
Kolson et al. 2002).
In this study, we noted a distinct pattern of cytokine/chemokine
expression in the brain. spleen. and serum of the HIV-1Tg and F344 rats in
response to LPS, both with and without ET. Identifying these distinct
cytokine/chemokine profiles may potentially be useful as indicators of the
onset and/or progression of certain disease processes, such as sepsis.
Further studies will be done to determine the relationship of viral protein
expression to the production of cytokines and chemokines during ET.
In our other study of CPP in the HIV-1Tg and control F344 animals, we
explored the hypothesis that the HIV-1Tg rat is more prone to the addictive
properties of morphine than the control animal F344 because expression of
MOR is up-regulated in the HIV-1Tg rat (Chang. Beltran et al. 2007). We
used the CPP test to measure the motivational salience of morphine paired
cues of the HIV-1Tg rats versus control, F344 rats. A dose of 3.5mglkg
morphine successfully established a CPP in both the HIV-1Tg and F344
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rats. However, an unanticipated finding was that rats that had morphine
paired with the white chamber failed to show any evidence of extinction,
whereas the rats that had morphine paired with the black chamber showed
successful extinction and the emergence of a reversed preference. When
the color of the morphine-paired chamber was not taken into consideration
in the statistical analysis, group averages suggested that extinction
occurred after 17 and 20 days for F344 and HIV-1Tg rats, respectively.
o

However, when the morphine-paired chamber was included as a factor in
the analysis, it was revealed that extinction occurred earlier in the rats for
whom morphine was paired with the black chamber, but not in the rats for
whom morphine was paired with the white chamber.
During a CPP test rats freely explore both sides of the apparatus, spending
more time overall on the morphine-paired side if a CPP is established. The
behavior of the rats in a CPP apparatus, however, is affected by factors
other than a CPP that are not typically assessed systematically in CPP
studies. When first placed in the apparatus the relative novelty of the
environment activates exploratory behavior that declines or habituates over
time. As exploratory behavior undergoes habituation the rats move less
and choose to settle in a preferred chamber if a preference is present
(Reid, Marglin et al. 1989). Rats may settle in one chamber because that
chamber accrued rewarding properties when it was paired with morphine;
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this is basic assumption of the CPP test. However, our present studies
suggest that following habituation of exploratory behavior rats may also
settle to one chamber when a natural preference for that chamber exists
that may not have been apparent in the preconditioning phase when the
novelty of the apparatus was activating high levels of exploratory behavior.
The presence or absence of natural preferences is a characteristic of the
CPP apparatus that has been considered in the literature. When morphine
is paired with the naturally preferred chamber, the observed CPP is
assumed to result from the sum of the natural preference and the
conditioned preference. When morphine is paired with the non-preferred
chamber, however, the conditioned rewarding properties of the previously
less preferred chamber will compete with the naturally preferred chamber.
If the newly acquired rewarding properties are sufficiently strong to compete
successfully with the natural preference a CPP will be observed, although it
is likely to be weaker than in subjects that had morphine paired with the
naturally preferred side. This is the reason that the drug is paired with the
non-preferred side when a biased CPP apparatus is used (Roma and Riley
2005). A successful CPP in a biased apparatus indicates that the
conditioned rewarding properties were sufficiently strong to overcome the
natural preference. With an unbiased apparatus the drug is not paired with
a preferred side although the drug-paired chamber is typically
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counterbalanced within groups. But the results of the present study
suggest that natural chamber preferences may not be apparent when a
single brief preconditioning test that is a common procedure as suggested
in the CPP literature is used. This is because that there is not sufficient
opportunity for the habituation of intense exploratory behavior to reveal the
natural preference When we analyzed the pre-conditioning and post
conditioning results separated into three 5-minute time segments no
statistically significant side preference was observed during preconditioning
in the two-chamber CPP apparatus used in the present experiment.
However, the post-conditioning data showed clear changes in preference
over the three 5-minute periods. As time passed rats generally explored
less and spent more time in the morphine-paired chamber. This pattern
was most pronounced in the rats that experienced morphine paired with the
white chamber.
There were animals that did not extinguish the morphine-induced CPP and
there were other animals that did show extinction. For clarity these are
discussed separately below.

Failed Extinction of a CPP
The extinction data indicated that the preference for the white morphine
paired side failed to weaken despite 17 (F344 rats) and 20 (HIV-1Tg rats)
days of exposure to the extinction procedure. Moreover, within-session
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increases in preference for the morphine-paired side was consistently
observed in the white-morphine paired rats, but not in the black-morphine
paired rats. We argue that the within-session increase in preference is due
to habituation of exploratory behavior. Evidence consistent with this
habituation interpretation is provided in Extinction 2 where spontaneous
recovery of exploratory behavior was observed as a result of the delay
between Extinction 2a and 2b. Our studies also show that the rats had a
natural preference for the white chamber that was not evident in the
preconditioning phase, but when paired with morphine this preference
became more evident. The natural place preference plus the conditioned
place preference may have synergized to augment the preference for the
white side. An alternative explanation is that morphine enhanced the
natural preference without inducing a CPP as it is typically characterized.
If the increased preference for the white chamber was due to the summing
of a natural preference and a CPP, then repeated exposure to the chamber
cues in the absence of morphine treatment should decrease the place
preference as the CPP undergoes extinction, but there was no evidence of
extinction in the white-morphine paired groups. It cannot be ruled out that
extinction would have been observed if additional extinction days were
given. However, the expectation of an increased likelihood of extinction
given sufficient extinction trials is based on the prevailing theoretical view
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that explains CPP as a case of classical conditioning that involves
predictive learning. Alternatively. the CPP procedure with morphine may
result in another form of behavioral plasticity that does not conform to a
predictive learning account of classical conditioning.
In the predictive learning model of classical conditioning the acquisition of
CPP is seen as involving an association between the discriminative
chamber cues and the rewarding properties of morphine. such that the
chamber cues predict the availability of morphine. In the extinction
procedure a new association is presumed to occur (i.e .• the chamber cues
no longer predict the availability of morphine) that supersedes the original
association, causing CPP to extinguish. When the rats are "reminded" of
the earlier predictive relationship in a reinstatement procedure the CPP
reemerges; that is. the morphine effect is once again anticipated. However.
there are several well documented cases of classical conditioning
procedures that result in a conditioned preference that do not extinguish.
When the consumption of a flavored saccharin solution is paired with a
carbohydrate solution that is pumped directly into the stomach, for example,
rats develop a strong preference for the flavored saccharin solution that is
highly resistant to extinction(Elizalde and Sclafani 1990; Drucker, Ackroff et
al. 1994). This suggests that some preferences that are established with
classical conditioning procedures may not be easily eliminated by
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extinction. A body of research has found similar effects in animals and
humans and is referred to as evaluative conditioning (Baeyens and De
Houwer 1995; De Houwer, Thomas et al. 2001). In evaluative conditioning
the positive value of the unconditioned stimilus is presumed to transfer to
the conditioned stimulus, increasing the liking of the CS. Therefore, the
positive value of the morphine US in the present study may have been
transferred to preferential discriminative chamber cues (white chamber) to
produce an enhanced preference that is highly resistant to extinction.
Indeed a persistent preference for cues previously paired with a
psychoactive drug would help explain an individual's life-time struggle with
drug addiction - the acquired preference for drug-paired cues never really
go away. Interestingly, numerous studies show that conditioned responses
to drug-paired cues can undergo extinction in animals, but the evidence of
similar extinction effects in humans is lacking (Myers and Carlezon 2010).
It is unclear what factors may be involved in whether a CPP undergoes
extinction or whether it persists indefinitely. One possible factor that may
influence resistance to extinction may be the type of morphine-paired cue.
A CPP that resists extinction may be more likely if there is a natural
preference for the paired cue before conditioning, even if the natural
preference is not immediately apparent early in testing because other
behaviors (e. g., exploratory behavior) mask the initial preference. Clearly
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not all preferred cues paired with a drug lead to CPP that fails to extinguish
since extinction is often observed in biased CPP procedures where the drug
is paired with an initially preferred side. An enhanced natural preference
may be most prominant when morphine is paired with contact cues (that is,
floor cues) because once rats make physical contact with the floor cues
they may prefer to maintain contact with these cues and reduce their
approach to other distal cues (Vezina and Stewart 1987).
The prevalence of CPP that is highly resistant to extinct is not well known.
Investigators often do not test for extinction of CPP because it is not
germane to the hypothesis being investigated. When extinction is a desired
outcome in an experiment (e.g., to test for reinstatement, for example) any
procedure that results in CPP that resists extinction may be interpreted as a
failed procedure and abandoned in favor of procedures that yield CPP
results more consistent with a predictive memory model interpretation.
Nevertheless there are several examples of high resistance to extinction of
morphine-induced CPP in the literature. Most recently, for example, Rutten
and colleagues reported that it took 18 fifteen-min ute-sessions to see
extinction of a 3.0 mg/kg dose and up to 45 fifteen-minute-sessions for a 10
mg/kg dose of morphine (Rutten K 2011). In another recent study, Narp
knockout mice failed to extinguish a morphine CPP. The authors conclude
that the Narp deletion disrupts the ability to update the predictive
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association between the CPP context cues and the drug reward (Crombag,
Dickson et al. 2009). However, this conclusion assumes that morphine
CPP procedures result in associative predictive learning. If CPP can also
result in the establishment of long lasting preference that is not
subsequently altered through extinction, then it is difficult to determine if
Narp deletion failed the updating of predictive learning (failed extinction) or

if it resulted in an enhanced behavioural plasticity that is better described as
evaluative conditioning. It is also possible that a preference for floor cues
may have been altered in the transgenic mice, rather than their propensity
to learn, and morphine induced an enhancement of this altered, natural
preference. We suggest here that the interpretation of extinction
performance of morphine CPP may be complicated by the behavioural
plasticity noted in the present CPP experiment and a more detailed analysis
of changing preferences across CPP sessions can help evaluate the factors
that contribute to the acquisition and maintenance of a place preference.
It is still plausible that a CPP was established along with an enhanced
natural preference in the white morphine paired animals, but the natural
preference dominated over the CPP. Thus, we examined place preference
early in an extinction session (minutes 1 -5), when the animals are
exploring at their maximum because habituation has not yet occurred. The
exploratory behavior early in the session may be guided primarily by the
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morphine predicitve cues (Le., CPP) independent of a natural preference.
The same can be said for minutes 16 -20 in Extinction 2b, because the
delay allowed the spontaneous recovery of exploratory behavior in this time
segment.
A preference for the morphine-paired side in the first 5 minutes was
observed that did not decrease over days in Extinction 1 or Extinction 2.
Thus, there was no evidence of extinction of morphine-pridictive cues over
days, even when just the first 5 minutes are examined. By the fourth time
segment (minutes 16-20) of Extinction 1 the preference for the morphine
paired time was even greater as exploratory behavior was habituating, but
during Extinction 2 the preference is again reduced as exploratory behavior
spontaneously recovers. Yet there is still no indication of a decreased
preference for the morphine-paired side over days. The same pattern was
also seen in the HIV-1Tg rats. The evidence suggests, therefore, that
morphine induced enhanced natural preference when it was paired with the
white chamber rather than a CPP. Perhaps this enhanced natural
preference is best described as a type of evaluative conditioning (Baeyens
and De Houwer 1995; De Houwer, Thomas et al. 2001). A limitation of the
evaluation conditioning hypotheSiS is that a control group that received no
morphine treatment but similar number of "extinction" exposures to the
chamber was not available to assess the strength of the natural preference

97

in the absence of morphine. Nevertheless, the evaluative conditioning
hypothesis is worth exploring given the many cases in the literature of
preferences that are highly resistant to extinction.
Extinction of a CPP
The same analysis of the data over time segments from the black-morphine
paired groups yielded evidence of the extinction of a CPP. The evidence
suggests that these groups established a CPP that overcame the natural
preference for the white chamber and that this CPP extinguished. Although
the black-morphine paired groups did not experience an enhancement of
the natural preference for the white chamber (because it was not paired
with morphine) the hypothesized natural preference for the white side
should still be present. As extinction of the CPP occurs the natural
preference for the white side should emerge. This is what was observed.
During the first 5 minutes of Extinction 1 there was a significant preference
for the morphine-paired side that persisted across days of Extinction 1 in
both the F344 and HIV-1Tg groups. By Extinction 2 the main effect of drug
was no longer evident, indicating that the CPP had extinguished.
During the fourth time segment (minutes 16-20) of Extinction 2a significant
reversal in preference from the black morphine-paired chamber to the white
saline-paired chamber was observed in the F344 rats. This preference
reversal from the black morphine-paired chamber to the white saline-paired
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chamber during minutes 16 - 20 in Extinction 2 was not observed in the
HIV-1Tg rats, however, suggesting that CPP was not fully extinguished in
the HIV-1Tg rats. An additional 3 days of extinction for the HIV-1Tg rats still
failed to result in a reverse preference during the first 5 minutes of the
extinction sessions, but the reverse preference was clearly evident in the
last 10 minutes of the extinction sessions.
The lack of preference reversal in the HIV-1Tg rats during the first 5
minutes of extinction suggests that the HIV-1Tg rats showed greater
resistance to extinction of a CPP than the F344 rats. A more substantial
resistance to extinction was observed in the HIV-1Tg rats in a previous
study (Chang and Connaghan 2011). nevertheless both studies support the
hypothesis that morphine has a greater rewarding efficacy in the HIV-1Tg
rats (Rutten K 2011). The difference in the magnitude of the resistance to
extinction that was observed between the two studies is most likely due to
the apparatus used. In the previous study a custom-made three
compartment apparatus was used that resulted in a very strong natural
preference for the smaller middle compartment. Many rats also showed a
slight preference for one of the two larger compartments. Morphine was
paired with the less preferred of the two larger chambers while saline was
paired with the other large chamber. The middle chamber was not paired
with any injection. To assess CPP the time in the two larger chambers
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were compared while the time in the middle chamber was not taken into
consideration. The rats spent most of their time in the naturally preferred
chamber, but when the times in the two larger chambers were compared a
significant CPP was observed that took significantly longer to extinguish in
the HIV-1Tg rats. Thus, in the previous study with a three-compartment
chamber the strong natural preference for the smaller chamber did not
compete directly with the CPP that was established in the larger chambers,
whereas in the current study with the two-compartment apparatus the
natural preference competed with the CPP. When morphine was paired
directly with the naturally preferred white chamber in the present study. the
preference was enhanced to be greater than rats that did not experience
morphine paired with their naturally preferred chamber.

Reinstatement of Cpp
A salient feature of drug addiction is relapse (Koob and Nestler 1997;
Kalivas and Volkow 2005). Even after long drug-free periods the subject
can relapse to drug seeking and use if exposed to small quantities of the
drug, to a drug-paired cue or to stress (O'Brien 1997; Kalivas and Volkow
2005). CPP has been used to measure reinstatement for extinguished
place preference by reintroduction of the drug (drug-priming) or to stressors
(Wang, Luo et al. 2000; Shaham, Shalev et al. 2003; Aguilar, Rodriguez
Arias et al. 2009; Chang 2010; Chang 2011 ).
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In the present experiment, we used morphine primes of 1mg/kg and 3.5
mg/kg in the HIV-1Tg and F344 rats for whom the morphine-induced CPP
was extinguished. The HIV-1Tg and F344 rats paired with the white and
black chamber did not show re-instatement of CPP at either dose of
morphine. The HIV-1Tg and F344 rats for whom morphine was paired with
the black chamber, preferred the saline-paired side during the
reinstatement test. This supports the argument that the rats had a natural
preference for the white side that was counteracted by the CPP, but now
that the CPP is extinguished they are choosing to spend more time on the
white side during all three time periods despite the reinstatement attempt. It
may be that this white side preference was overcome by the initial CPP, but
the reinstatement effect was just not strong enough to overcome this
natural preference.
There is considerable research indicating that there are major differences in
the neurocircuitry and neurobiology of reinstatement by drug-priming, by
cues and by stressors (Shaham, Shalev et al. 2003; Bossert, Ghitza et al.
2005). Stewart and colleagues show that the corticotrophin-releasing factor
and noradrenergic dependent pathways were primarily involved in foot
shock stress induced relapse but had little effect on drug-induced relapse
(Shaham, Erb et al. 2000; Stewart 2000; Erb S 2001; Stewart 2003). There
are studies which indicate that stress is a co-risk-factor in the drug-addiction
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relapse in the HIV-1 positive population (Demas, Schoenbaum et al. 1995;
Rotheram-Borus, Rosario et al. 1995; Back, Dansky et al. 2001; Tull,
Trotman et al. 2009). Under foot shock stress the F344 and HIV-1Tg rats
that had the morphine paired with the white side continued to show a
preference for the white side. However, no statistically significant effects
were observed in the F344 or HIV-1Tg rats that had morphine paired with
the black side. This result may suggest that the stress reinstated a CPP
sufficient enough to counteract the preference for white, but not enough to
reverse the preference for the morphine-paired side. An alternative
explanation is that the black-morphine paired animals were showing a
smaller preference for the white side by the end of extinction (the natural
white side preference was not enhanced for them because it was never
paired with morphine) and in these reinstatement tests the smaller
preference is no longer evident because of the reduced statistical power as
a result of reducing the number of subjects by about half.
The failure to observe reinstatement effects in this experiment precluded
the test of the hypothesis that HIV-1Tg and F344 rats differ in their
sensitivity to morphine. There was some evidence, however, that the HIV
1Tg rats display a greater resistance to extinction of a morphine CPP; a
result that is consistent with a previous experiment using a three
compartment biased CPP apparatus (Chang 2011). These differences in
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resistance to extinction of a morphine CPP supports the hypothesis that
viral proteins alters the effects of morphine on behaviour, but more studies
and a better understanding of the behavioural plasticity that occurs in the
morphine CPP procedure is needed before these effects of viral proteins
can be elucidated.

Conclusions and Future Direction
The data from our study endotoxin -induced cytokine chemokine-profile in
the HIV-1Tg and control F344 animals provides a comprehensive picture of
the neuroimmune responses to infection during ET, and strongly suggest
that the presence of HIV-1 viral proteins may exacerbate those responses.
These findings also suggest the potential use of experimentally defined
cytokine/chemokine expression profiles as indicators of altered immune
function in various disease states.
Our results of the CPP study in HIV-1Tg rats failed to show reinstatement
however the HIV-1 Tg rats did take a longer time to extinguish the morphine
induced CPP, which supports our hypothesis that the persistent presence of
viral proteins may lead to an increased propensity for morphine induced
motivational salience. Moreover, this data suggested that the CPP
procedure itself may result in a behavioural plasticity that does not conform
to the Pavlovian/memory model.
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Future studies

Our study of endotoxin-induced cytokine- and chemokine-profiles in the
HIV-1 Tg, provided valuable information of the specific inflammatory
cytokine, chemokine and their receptors' genes that were modulated during
ET in the HIV-1Tg rat, it would be interesting to study the protein levels of
these modulated genes:
•

IL-1a, IL-1j3, and IFN-y in the spleen as these genes were 4- to 82
fold greater in the spleen of the HIV-1Tg rats compared to the F344
rats in both the single LPS exposure (SS+L) and ET (LL+L)

•

Cytokine receptors -IL-1 r2, IL-2rj3, IL-2ry, IL-5ra, IL-6ra, IL-6st. in
the brain as these were differently modulated in the brains of the
HIV-1Tg rats compared to the F344 rats in response to LPS in both
the ET state and after a single exposure to LPS

•

In the brain, Ccl2, Cxcl1, Cxcl2, Cxcl10, and Cxcl11, which were
levels, which differently modulated in the brains ofthe HIV-1Tg rats
compared to the F344 rats in response to LPS in both the ET state
and after a single exposure to LPS

•

In the spleen, Cc12, Cc17, Cc19, Cxcl1 and Cxcl2 levels

•

Ccr2, Ccr3. Ccr4, Ccr5. Ccr7, Cxcr3, Ccr10, Ccr3, Cx3cr1, IL-8rj3,
and Xcr1, in the spleen
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MOR is upregulated in the HIV-1Tg rat and we hypothesize that this may
have lead to the differences in the endotoxin-induced cytokine/chemokine
profiles between the HIV-1Tg and control animals as MOR is known to
modulate cytokine/chemokine networks. To explore the role of MOR in
modulation of cytokine- chemokine networks during ET, it would be
reasonable to study these cytokine/chemokine genes modulated in this
study during ET in MOR knock out rats to compare with the results obtained
with F344 rats in ET state in our study.

Our morphine CPP study in HIV-1Tg rats has characterized this important
HIV-1 model and provides novel and valuable information on morphine
induced CPP, which may result in a behavioural plasticity that does not
conform to the Pavlovian/memory model.
In our morphine-induced CPP study we noted that for all animals their
preference for the white chamber was enhanced by morphine, however,
this preference was not initially noted in the pre-conditioning phase. A
future study could explore if there is an initial preference of the animals for a
particular chamber by way of a longer pre-conditioning phase (3-days). If a
preference for the animals is observed in the pre-conditioning phase then a
biased design (versus the balanced design) for establishing a CPP could be
used where morphine is paired with the non-preferred chamber during the

105

conditioning phase. It would be interesting to explore if the "enhanced"
preference for one of the chambers still develops in the animals after
morphine-treatment using a biased design. Further if a morphine-induced
CPP is successfully produced using the biased design it would be
interesting to study the difference in the rate of extinction and in the
reinstatement of a drug-induced and/or stress-induced CPP between the
HIV-1Tg and control F344 rats. This will investigate our hypothesis that
HIV-1Tg may be more prone to morphine addiction due to the upregulation
of MOR in HIV-1Tg rats.
It would be of interest to know if extinction would eventually happen the
animals who had morphine paired with the white side and did not show
extinction. But rather than give many more extinction trials, which may
require weeks of extinction exposure, a more practical approach would be
to reverse the conditions and retrain the animals but this time pair
morphine with the black side chamber. This reverse pairing should change
the preference as they learn that black is now associated with morphine
(reversal and extinction are similar in that they both involve a new learning,
but reversal learning should be faster because of the actual presence of
morphine). Also, if it would let us explore if the HIV-1Tg rats do indeed
learn more slowly, if any observed reversal of the preference is slower in
the HIV-1Tg rats compared to the F344 rats.
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